Tag: Priapus Shot

Platelet-rich plasma (PRP) therapy has served orthopaedics, wound healing, and dermatology for over two decades. Its application to male sexual health — specifically as the P shot — represents one of the newer frontiers of regenerative medicine. Unlike oral medications for erectile dysfunction, which manage symptoms, PRP-based treatment targets the underlying vascular and tissue architecture of the penis. Understanding exactly what happens during a first consultation helps men approach the process with accurate expectations. This article outlines each stage of a P shot London consultation in precise clinical terms. Specifically, it covers the procedural steps, the biological rationale, the evidence base, key limitations, and what realistic outcomes look like.

What Is the P Shot?

The P shot — also referred to as the priapus shot, Pshot, or P-shot — is a procedure in which a practitioner extracts platelet-rich plasma from the patient’s own blood and injects it into specific regions of the penis. The term “priapus shot” derives from the trademarked Priapus Shot® protocol that Dr Charles Runels developed in the United States.

The procedure falls within the broader category of regenerative treatment for male health in the UK. It is not a surgical intervention. Practitioners use no implants, foreign substances, or synthetic fillers. Because the plasma comes entirely from the patient’s own blood draw, the treatment qualifies as autologous.

Furthermore, the priapus shot London and wider P shot UK market has grown substantially in the past five years. This growth reflects increasing patient interest in non-surgical treatment for erectile dysfunction in London and other major UK cities, as well as growing awareness of PRP-based regenerative therapy for ED.

Who Seeks a P Shot Consultation?

Men seek a P shot consultation for a range of clinical reasons. The most common include:

• Erectile dysfunction (ED) that has not responded adequately to oral PDE5 inhibitors such as sildenafil or tadalafil
• Post-prostatectomy erectile dysfunction
• Peyronie’s disease (penile curvature caused by fibrous scar tissue)
• Lichen sclerosus affecting the penis
• Interest in penile injection growth or tissue remodelling as a non-surgical option
• Reduced penile sensitivity following nerve injury or pelvic surgery

Erectile dysfunction affects up to one in five men in the UK — approximately 4.3 million people. A 2022 cross-sectional study published in BMC Urology found that, of 12,490 men surveyed in the UK, 41.5% reported ED, and 7.5% met criteria for severe ED. Despite this prevalence, many men delay or avoid seeking treatment. As a result, a private consultation provides a confidential, structured environment in which to assess suitability and explore all available options.

The Evidence Base for PRP and Erectile Dysfunction

Before describing what happens during a consultation, it is worth establishing what the evidence currently shows.

A 2024 meta-analysis, evaluated using the Cochrane method, analysed 12 controlled trials involving 991 patients and 11 single-arm trials with 377 patients. Notably, the PRP group achieved better outcomes in terms of International Index of Erectile Function (IIEF) scores and minimal clinically important difference (MCID) compared to control groups.

Additionally, a 2025 narrative review published in UroPrecision identified five randomised clinical trials, two meta-analyses, and a systematic review on intracavernosal PRP for ED. The review highlighted significant variability in PRP preparation, dosage, and follow-up protocols, which hindered direct comparison across studies.

Furthermore, a 2024 systematic review and meta-analysis published in Translational Andrology and Urology concluded that PRP demonstrates significant efficacy and safety in treating ED. However, the authors noted that most included literature consisted of single-arm studies, and that researchers need to produce higher-quality evidence for validation.

In plain terms, current evidence is encouraging but not yet definitive. Consequently, larger, standardised randomised controlled trials remain necessary. Any reputable clinic offering P shot treatment should communicate this clearly during consultation.

Step 1 – Pre-Consultation Screening and Medical History

The first phase of a P shot London consultation is a thorough clinical assessment. This is not a brief intake form. Instead, a qualified practitioner takes a detailed medical history covering the following areas.

Cardiovascular health. Erectile dysfunction frequently signals underlying vascular disease. The NHS and the British Heart Foundation note that ED shares risk factors with coronary artery disease, including hypertension, dyslipidaemia, and type 2 diabetes. Therefore, the practitioner will ask about these conditions directly.

Current medications. Anticoagulants (e.g., warfarin, apixaban, rivaroxaban) affect platelet function and may influence PRP preparation. Similarly, testosterone replacement therapy, antidepressants, and antihypertensives can all contribute to erectile dysfunction and the practitioner must record them.

Surgical history. Prior pelvic surgery, prostatectomy, or urological procedures alter the neural and vascular landscape of the penis. This history directly informs whether P shot treatment is likely to benefit the patient.

Duration and severity of symptoms. Practitioners typically use validated scoring tools such as the International Index of Erectile Function (IIEF-5) questionnaire to quantify ED severity objectively.

Lifestyle factors. Smoking, alcohol consumption, body mass index, physical activity levels, and sleep quality all influence erectile function and treatment response.

In addition to the above, this stage may include a brief physical examination and a review of relevant blood tests, including testosterone, HbA1c, and lipid profile.

Step 2 – Candidacy Assessment and Shared Decision-Making

Following the history-taking stage, the practitioner assesses whether the patient suits P shot treatment.

General inclusion criteria in clinical practice include:

• Mild to moderate vasculogenic ED
• Peyronie’s disease (plaque formation)
• Post-treatment ED following prostate cancer therapy
• Interest in penile injection growth in the context of penile rehabilitation

Conversely, the following contraindications may exclude a candidate:

• Active infection at the injection site
• Blood disorders affecting platelet function
• Platelet count below the threshold the practitioner needs for effective PRP preparation
• Active malignancy
• Use of anticoagulant medication that the patient cannot temporarily pause

This is also the stage at which the practitioner presents all available treatment options. P shot treatment is one option within a broader toolkit. For many men, oral PDE5 inhibitors remain the first-line treatment that NICE guidelines recommend. Moreover, vacuum erection devices, penile rehabilitation protocols, and psychosexual therapy may also be relevant. The consultation process should enable informed decision-making, not steer the patient toward any single treatment.

At pshots clinic uk, consultations are led by Dr Syed Nadeem Abbas (MBBS, MRCS RCS Edinburgh, MRCGP, MSc Aesthetic Plastic Surgery with Distinction — Queen Mary University London), who trained at Cambridge, Oxford, and the Royal London Hospital and brings both surgical and regenerative medicine expertise to this assessment.

Step 3 – Explanation of the Procedure and Consent

Once the patient confirms suitability and chooses to proceed, the practitioner provides a detailed explanation of the procedure itself.

How PRP Is Prepared

The practitioner derives platelet-rich plasma from the patient’s own peripheral blood. First, a nurse takes a standard venous blood draw of approximately 30–60 ml, usually from the antecubital fossa (the inner elbow). Next, the team processes the blood in a centrifuge — a device that spins rapidly to separate blood components by density. This yields three distinct layers:

1. Red blood cells (at the base)
2. A buffy coat containing white blood cells and platelets
3. Platelet-poor plasma (at the top)

The practitioner then carefully extracts the platelet-rich fraction. Depending on the centrifuge system in use, the resulting PRP typically contains a platelet concentration three to five times higher than baseline whole blood. Platelets release growth factors including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), vascular endothelial growth factor (VEGF), and insulin-like growth factor (IGF-1). These growth factors support tissue repair, angiogenesis, and cellular regeneration.

Injection Protocol

Before the injection, the practitioner applies a topical anaesthetic cream (typically lidocaine-based) to the penis. In addition, the team may administer a penile block — a local anaesthetic injection — to ensure the patient remains comfortable throughout.

The practitioner then injects the PRP into specific anatomical regions. These typically include:

• The corpora cavernosa (the paired erectile tissue cylinders)
• The glans penis (the head of the penis), if clinically indicated
• The corpus spongiosum, depending on the clinical presentation

The total injection time is short. Overall, the entire procedure — from blood draw to completion of injections — typically takes between 30 and 45 minutes.

After the injection, the practitioner may recommend a vacuum erection device (VED). Some protocols use the VED immediately post-injection to distribute the PRP throughout the erectile tissue and encourage blood flow.

Step 4 – The Procedure Itself

On the day of the procedure — which may occur during the same session as the consultation or on a separate appointment — the team follows this sequence:

Blood draw. A nurse or practitioner draws venous blood from the arm. This takes two to three minutes.

Centrifugation. The team processes the blood in a medical centrifuge. This step takes approximately 10 to 15 minutes.

PRP preparation. The practitioner extracts the platelet-rich fraction using sterile technique and draws it into a syringe.

Topical anaesthesia. The practitioner applies lidocaine cream to the penis and allows it to take effect for 20 to 30 minutes.

Penile block (if used). The practitioner may administer a local anaesthetic injection to the base of the penis.

PRP injection. Using a fine-gauge needle, the practitioner injects the PRP into the pre-determined sites, using multiple injection points as needed.

Post-procedure care. The practitioner may briefly apply ice packs or cold compresses. Before leaving, the patient receives written aftercare instructions.

The P shot does not require general anaesthesia, inpatient admission, or a surgical environment. As a result, most patients travel home independently after the procedure.

Step 5 – Aftercare, Recovery, and Follow-Up

Immediate Recovery

Minor side effects are common and expected. These include:

• Mild bruising at the blood draw site
• Temporary swelling of the penis (usually resolving within 24–72 hours)
• Mild discomfort or pressure at injection sites
• Transient discolouration

These effects align with the normal tissue response to any intradermal or intracavernosal injection.

Activity Restrictions

The practitioner typically advises patients to avoid sexual activity for 24–48 hours after the procedure. Similarly, patients should restrict strenuous physical exercise for a short period. However, normal daily activities — including light exercise and desk-based work — can usually resume on the same day.

Timeline of Results

This is an area where practitioners must carefully manage patient expectations. PRP does not produce instantaneous results. Instead, the proposed mechanism of action — growth factor release, angiogenesis, and tissue remodelling — unfolds as a biological process over weeks to months.

Clinical studies suggest that some patients notice improvement in erectile function within four to twelve weeks. Others require multiple sessions or do not experience a measurable response. Some people notice changes within a few days; however, others may need several months or multiple P shots before they see any difference at all.

Currently, no consensus exists on the optimal number of treatment sessions or the ideal interval between them. Some protocols suggest a single treatment with review at three months. Others recommend two or three sessions spaced four to six weeks apart.

What P Shot Before and After Results Typically Show

Published P shot before and after outcomes — whether from clinical trials or observational case series — generally report improvements in IIEF scores, self-reported erectile rigidity, and in some cases, subjective improvements in penile sensitivity. In clinical practice, P-shot before and after assessments use the IIEF-5 questionnaire as the primary validated outcome measure.

Importantly, no peer-reviewed evidence supports claims that the P shot produces reliable or permanent increases in penile length or girth. Male enlargement injections cost UK providers vary significantly, and patients should assess claims about size increase critically and discuss them openly with the practitioner.

Priapus Shot Price: What to Expect in the UK

The priapus shot price in the UK reflects the clinical complexity of the procedure, the PRP preparation system the clinic uses, practitioner expertise, and location. In London, a single P shot treatment session typically costs between £800 and £2,500.

Some clinics offer package pricing for multiple sessions. Men who research male enlargement injections cost UK options should clarify exactly what each quoted price covers: consultation fee, blood processing, anaesthesia, the injection itself, and follow-up review.

The NHS does not offer this procedure, and standard health insurance in the UK does not cover it.

Limitations and Honest Expectations

The following limitations are critical for every patient to understand.

The evidence base, whilst growing, remains preliminary. Most randomised controlled trials to date are small, use different PRP preparation systems, and follow patients for short periods. The P shot does not feature in NICE clinical guidelines for erectile dysfunction.

Response is not universal. A significant proportion of patients do not experience clinically meaningful improvement. Specifically, men with severe vasculogenic ED, extensive nerve damage, or uncontrolled metabolic disease are less likely to respond than those with mild to moderate ED.

It is not a cure. PRP therapy for men’s performance issues works best as a regenerative adjunct, not a definitive cure. Patients must also pursue ongoing management of underlying conditions — including cardiovascular disease, diabetes, and hypertension.

Results are not permanent. Where improvement does occur, the duration of effect is not well established. Some patients report benefit lasting 12 to 18 months; others report earlier decline. Consequently, repeat treatments may become necessary.

Combination approaches may be needed. Advanced PRP solution for erectile dysfunction tends to produce the best results when clinicians combine it with lifestyle modification, optimised medical therapy, and — where appropriate — psychosexual support.

Frequently Asked Questions

Is the P shot painful?

The topical anaesthetic cream and, where the practitioner uses it, the penile nerve block significantly reduce discomfort. Most patients report feeling pressure rather than sharp pain during the injection phase. Mild soreness for 24–48 hours after the procedure is common.

How many sessions will I need?

No universally agreed protocol currently exists. Many clinics begin with a single session and reassess at eight to twelve weeks. If the patient shows partial benefit, the practitioner may recommend a second session. Your practitioner will discuss the most appropriate plan for your clinical presentation.

Is the P shot safe?

Because the patient’s own blood provides the PRP, the risk of allergic reaction or immune rejection is negligible. The primary risks relate to the injection procedure itself: bruising, swelling, infection, and temporary discomfort. Serious complications are rare.

Does the P shot treat Peyronie’s disease?

Some clinical protocols incorporate PRP as part of a multi-modal approach to Peyronie’s disease. However, the evidence for PRP in Peyronie’s remains limited and inconclusive. Men with this condition should discuss all available options — including traction therapy, collagenase injections (Xiaflex), and surgery — with a specialist.

Can the P shot combine with other treatments?

Yes. Clinicians frequently use PRP-based regenerative therapy for ED alongside lifestyle modification, PDE5 inhibitors, low-intensity shockwave therapy (Li-ESWT), and testosterone optimisation where clinically indicated. Combination approaches are often more effective than any single intervention on its own.

How does the P shot differ from penile filler?

Penile fillers use hyaluronic acid — a temporary dermal filler — to add volume to the shaft or glans. In contrast, the P shot uses the patient’s own platelet-rich plasma to stimulate biological tissue repair. They are categorically different procedures with different mechanisms, indications, and risk profiles.

What is the difference between the P shot and a penis shot from a GP?

A general practitioner may offer intracavernosal injections of vasoactive agents such as alprostadil (Caverject) as an erectile dysfunction treatment. These agents directly dilate blood vessels to produce an erection. In contrast, the P shot uses PRP to pursue long-term tissue regeneration, not immediate erection induction. They are separate treatment modalities.

Key Takeaway

A first P shot London consultation is a structured, evidence-informed clinical encounter. It is not a cosmetic appointment or a quick procedure. Rather, it involves a thorough medical history, candidacy assessment, shared decision-making, procedural explanation, and formal consent — all before any injection takes place.

Men’s intimate health treatment in London continues to evolve as regenerative medicine expands its evidence base. Natural ED treatment using PRP therapy remains an area of active research, with promising early data that is not yet sufficient to place PRP in mainstream clinical guidelines. Nevertheless, for men who have not responded to conventional treatments, or who wish to explore non-surgical options, a structured consultation with a qualified practitioner is the appropriate first step.

Ultimately, realistic expectations, honest communication, and thorough clinical assessment are the hallmarks of a responsible consultation. Any clinic that cannot explain what evidence supports the procedure, what its limitations are, and what realistic outcomes look like should be approached with caution.

The question worth considering before booking any consultation is this: does the clinic you are approaching offer a full clinical assessment, or simply a treatment?

Read more: Platelet-Derived Growth Factor in PRP: How It Helps Repair Penile Tissue

Priapus Shot London – The Science Behind Platelet-Rich Plasma Therapy

P shot London

Platelet-rich plasma (PRP) quality is not uniform. Two clinics can both claim to offer a P shot UK treatment, yet produce PRP of fundamentally different platelet concentrations. The difference often comes down to a single procedural variable: the centrifuge protocol used.

Most discussions around the priapus shot focus on what the treatment does — stimulating tissue repair, promoting vascular growth, and supporting erectile function.

Far fewer researchers address the upstream question of how clinicians prepare PRP and why the preparation method directly influences clinical outcomes.

This article examines dual-spin centrifugation: what it is, how it compares to single-spin methods, what the peer-reviewed evidence shows, and why it matters specifically in the context of regenerative treatment for male health in the UK.

What Is Platelet-Rich Plasma and How Is It Relevant to the P Shot?

PRP is an autologous blood product. It is derived from the patient’s own blood and processed to concentrate platelets above normal physiological levels.

Whole blood contains approximately 150,000 to 400,000 platelets per microlitre (μL). Therapeutic PRP targets concentrations that substantially exceed this baseline.Peer‑reviewed studies show that platelet concentrations above one million per μL deliver meaningful growth factors and drive soft tissue regeneration.

Platelets are not simply clotting agents. They carry dense granules packed with bioactive molecules, including platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGF-β), and insulin-like growth factor (IGF). These molecules act on local tissue to promote angiogenesis, collagen synthesis, and cellular proliferation.

In P‑shot treatment — formally called the Priapus shot — clinicians inject PRP into the corpus cavernosum and surrounding penile tissue. The rationale is that concentrated growth factors may support endothelial repair, smooth muscle regeneration, and neurovascular recovery within the erectile chambers.

Centrifugation: The Core Step in PRP Preparation

Centrifugation mechanically separates blood components according to their density.A centrifuge spins a tube at defined speeds (measured in revolutions per minute, or RPM) for a defined duration. Gravity-like forces separate red blood cells, white blood cells, platelets, and plasma into distinct layers.

The goal in PRP preparation is to discard the red cell fraction and concentrate platelets within the smallest possible plasma volume.

Centrifuge protocols vary considerably across clinics. The two principal approaches are single-spin and dual-spin (also called double-spin) centrifugation.

Single-Spin Centrifugation

Single-spin protocols apply one centrifugation cycle. The blood is spun once, separating into three broad layers: a red cell pellet at the bottom, a buffy coat (platelet-enriched layer) in the middle, and platelet-poor plasma at the top.

The clinician then draws off a volume of plasma above the buffy coat, hoping to capture a platelet-enriched fraction. This method is faster and simpler. However, the separation is incomplete. Platelet yield is lower, and the resulting PRP often contains a higher proportion of red and white blood cells, which can introduce pro-inflammatory mediators into the final product.

Dual-Spin (Double-Spin) Centrifugation

Dual-spin centrifugation adds a second centrifugation cycle. The first spin, typically at a lower RPM (soft spin), separates the red cells and produces a platelet-rich plasma fraction. This supernatant is then transferred to a second tube and centrifuged again at a higher RPM (hard spin). The hard spin further concentrates the platelets by pelleting them at the base of the second tube. The clinician then removes most of the overlying platelet-poor plasma, leaving a small, highly concentrated platelet suspension.

This two-stage process delivers a significantly higher platelet concentration per unit volume compared to single-spin methods. It also improves purity by reducing red and white blood cell contamination.

What the Evidence Shows: Single-Spin Versus Dual-Spin

The clinical evidence base for dual-spin superiority comes primarily from the hair restoration literature, where PRP has been more extensively studied. However, the centrifuge science is directly applicable to penile injection growth treatments.

Platelet Yield

A 2025 systematic review and meta-analysis published in Frontiers in Medicine (PMC12318733) compared single-spin and double-spin PRP centrifugation methods in the context of androgenic alopecia treatment. The analysis drew on randomised controlled trials and found that double-spin centrifugation produced statistically significantly higher platelet counts in the final PRP product compared to single-spin methods.

A preliminary randomised double-blind clinical trial published in the Journal of Clinical and Aesthetic Dermatology (JCAD) — examining thrombocyte count and clinical outcomes — similarly demonstrated that double-spin PRP yielded higher platelet concentrations. The clinical relevance of this difference was reflected in measurable hair regrowth outcomes, supporting the mechanistic link between platelet concentration and tissue response.

Growth Factor Delivery

Higher platelet concentration correlates with greater growth factor release at the injection site. PDGF, VEGF, and TGF-β concentrations are proportional to platelet density in the final PRP preparation. In PRP-based regenerative therapy for ED, this is mechanistically important because endothelial dysfunction — a core driver of vasculogenic erectile dysfunction — responds to VEGF-mediated angiogenic signalling.

White Blood Cell Content and Inflammatory Risk

Dual-spin protocols generally reduce residual white blood cell (WBC) content in the final product. Leukocyte-rich PRP has been associated with greater post-injection inflammation in some tissue contexts. While the clinical significance in penile injection applications requires further study, minimising unnecessary inflammatory mediators remains a sound principle in any regenerative injection therapy.

Evidence in Erectile Dysfunction Specifically

A 2024 meta-analysis published in PLOS ONE examined 12 controlled trials involving 991 patients who received intracavernosal PRP for erectile dysfunction. The PRP group showed significantly better outcomes on the International Index of Erectile Function (IIEF) score compared to controls (standardised mean difference = 0.59; 95% CI: 0.34–0.84). The relative risk of achieving minimal clinically important difference was 1.94.

The authors noted, however, that heterogeneity in PRP preparation protocols — including centrifuge method — limited the ability to draw firm conclusions about optimal technique. This finding underscores the importance of standardising PRP preparation in future trials and in clinical practice.

Clinical Implications for P Shot UK Patients

The practical significance of centrifuge protocol selection is not merely technical. It directly affects what a patient receives.

Concentration Targets

Research from the UroPrecision 2025 narrative review specifies that achieving platelet concentrations exceeding one million platelets per μL is considered optimal for promoting soft tissue healing. Single-spin protocols often fall short of this threshold. Dual-spin methods are more reliably capable of producing concentrations in this therapeutic range.

A patient attending for a non-surgical treatment for erectile dysfunction in London should have confidence that the PRP they receive meets clinically meaningful concentration standards — not merely that blood has been processed.

Consistency Across Treatment Cycles

Men seeking P shot treatment commonly attend for multiple treatment sessions over several months. Consistent PRP quality across sessions is necessary for cumulative benefit. Dual-spin centrifugation, when conducted with a validated protocol, offers greater batch-to-batch consistency than informal single-spin approaches.

Equipment Matters

Not all centrifuges are equal. Dedicated medical-grade PRP centrifuges, such as the Arthrex Angel system, incorporate optical sensors to automate buffy coat identification and improve precision. These systems are considerably more accurate than standard laboratory centrifuges adapted for clinical use. The use of validated equipment is a meaningful quality indicator when evaluating advanced PRP solution for erectile dysfunction providers in the UK.

Understanding the P Shot Procedure in Context

The P shot — also referred to in clinical contexts as a priapus shot, penile injection growth treatment, or p injection — follows a standardised sequence regardless of the specific clinic or practitioner.

Procedure Overview

Blood is drawn from the patient’s arm (typically 10–60 ml depending on protocol). The blood undergoes centrifugation — either single or dual spin. The processed PRP is drawn into a syringe. A topical anaesthetic cream is applied to the treatment site. The PRP is then injected into the corpus cavernosum and, in some protocols, the glans.

The entire procedure takes approximately 45 to 60 minutes at most clinics offering P shot London treatments.

P Shot Before and After: What the Evidence Supports

P shot before and after comparisons in published literature typically assess IIEF domain scores, penile blood flow via Doppler ultrasound, and patient-reported quality of life.

A 2025 systematic review on PRP for vasculogenic erectile dysfunction (published in the World Journal of Men’s Health) noted improvements in IIEF scores and peak systolic velocity in Doppler studies following intracavernosal PRP. These findings suggest vascular and functional improvement at tissue level, though the authors emphasised that large-scale, long-duration randomised controlled trials remain necessary.

P-shot before and after results vary between patients. Factors influencing response include baseline severity of erectile dysfunction, vascular health, age, and — critically — the quality of PRP administered.

What the P Shot Does Not Do

The P‑shot does not qualify as a surgical intervention. Patients cannot rely on it for permanent results in every case. Nor does it consistently replace phosphodiesterase type 5 inhibitors (PDE5i) such as sildenafil or tadalafil. In addition, the UK Medicines and Healthcare products Regulatory Agency (MHRA) has not licensed it as a specific treatment for erectile dysfunction in the way pharmaceutical agents are.

Men pursuing natural ED treatment using PRP therapy should approach the treatment with realistic expectations, informed by evidence rather than marketing claims.

Why Dual-Spin Matters Specifically in the UK Context

In the United Kingdom, PRP treatments for male sexual health operate outside standard NHS provision. The NHS does not routinely commission PRP-based penile injections for erectile dysfunction. Private providers, therefore, bear a higher responsibility for clinical transparency and quality standards.

The British Society for Sexual Medicine (BSSM) recommends evidence-based approaches to erectile dysfunction treatment London providers should follow. NICE guideline NG181 (Erectile dysfunction: assessment and management, 2021) covers pharmacological and surgical options but does not address PRP therapy, reflecting the current absence of sufficient trial data at national guideline level.

This regulatory gap makes it all the more important for private UK clinics to self-impose high preparation standards. A clinic that employs dual-spin centrifugation with validated medical-grade equipment, appropriate PRP concentration verification, and trained practitioners is substantively different from one that adopts minimal protocols.

Clinics offering male enlargement injections cost UK pricing should disclose their centrifuge protocol alongside their treatment costs, as preparation quality is directly linked to clinical value.

Limitations of Current Evidence and Areas for Future Research

It is important to acknowledge the limitations of the existing evidence base. Most studies comparing centrifuge protocols have been conducted in hair restoration, not urology. Direct comparative trials of single-spin versus dual-spin PRP for erectile dysfunction specifically are not yet available.

The mechanistic inference — that higher platelet concentrations produce better clinical outcomes in penile tissue — is biologically reasonable and supported by growth factor pharmacology. However, it has not been proven in large-scale randomised controlled trials restricted to ED applications.

PRP research also faces the challenge of non-standardisation. Protocols differ in spin speed, spin duration, tube volume, anticoagulant type, and activation method. This heterogeneity makes meta-analysis conclusions inherently limited. Future high-quality trials should pre-specify centrifuge protocols to allow meaningful comparison.

Men who are considering PRP therapy for men’s performance issues should be informed of these evidentiary limitations by their treating clinician before consenting to treatment.

What to Ask a Provider Before Booking a P Shot UK Treatment

Given the variation in preparation standards across providers, patients have a right to ask direct questions about clinical protocols. The following questions are clinically relevant:

What centrifuge protocol do you use — single-spin or dual-spin?

The answer should specify the number of centrifugation cycles and, ideally, the target platelet concentration.

What medical-grade centrifuge system do you use?

Validated systems with optical sensors or standardised kits are preferable to adapted laboratory equipment.

How do you verify the platelet concentration of the final product?

Point-of-care platelet counting, where available, provides the most direct quality confirmation.

What volume of blood do you collect, and what is your final PRP yield?

Higher input volumes generally allow for a more concentrated final product.

Is your practitioner trained and what are their qualifications?

Penile injections carry procedural risks. Practitioner training and medical qualifications are non-negotiable considerations.

At pshots clinic UK, P shot UK treatments are led by Dr Syed Nadeem Abbas (MBBS, MRCS RCS Edinburgh, MRCGP, MSc Aesthetic Plastic Surgery with Distinction — Queen Mary University London), with training from Cambridge, Oxford, and the Royal London Hospital, and the clinic operates from Harley Street, Marylebone.

Frequently Asked Questions (FAQ)

What is the difference between a single-spin and dual-spin centrifuge in PRP preparation?

A single-spin centrifuge applies one centrifugation cycle, producing a moderate platelet concentrate. A dual-spin centrifuge applies two cycles — a soft spin followed by a hard spin — to achieve a significantly higher platelet concentration in a smaller final volume. The dual-spin method delivers more growth factors per injection.

Does the centrifuge type affect P shot results?

Yes. The biological activity of PRP depends on platelet concentration. Higher platelet concentrations contain more growth factors, which are the active agents driving tissue repair and vascular regeneration. Using dual-spin centrifugation is a key step in producing clinically effective PRP for P shot UK treatments.

What platelet concentration is needed for effective PRP in erectile dysfunction?

Research indicates that platelet concentrations exceeding one million platelets per μL are associated with meaningful soft tissue healing. Single-spin methods may not reliably achieve this threshold. Dual-spin protocols are more consistently capable of reaching clinically relevant concentration levels.

How many treatment sessions does the P shot require?

Most clinical protocols involve an initial series of two to three treatment sessions spaced four to six weeks apart. Some patients require maintenance sessions thereafter. Individual responses vary, and no fixed number of sessions guarantees a specific outcome.

Is the P shot available on the NHS?

No. PRP-based penile injections are not currently offered on the NHS for erectile dysfunction. NICE guideline NG181 does not include PRP as a recommended treatment. The P shot is available only through private providers in the UK.

What are the risks of a P shot treatment?

As with any injectable procedure, risks include localised bruising, temporary swelling, and discomfort at the injection site. Serious complications are rare when the procedure is performed by a trained medical practitioner using sterile technique. There is also a small risk of priapism (prolonged erection), which requires urgent medical attention. Patients should receive a full risk consultation before treatment.

What does the priapus shot cost in the UK?

Priapus shot price in the UK varies between private providers. Pricing depends on the clinic’s location, the practitioner’s qualifications, the centrifuge equipment used, and the volume of PRP prepared. Patients should request full cost transparency, including details of what is included in the quoted price, before proceeding.

How long do P shot results last?

Clinical evidence suggests that improvements in erectile function can be observed for six to twelve months following treatment, though individual variation is significant. Long-term outcome data from large-scale randomised controlled trials are not yet available.

Key Takeaway

The quality of PRP used in a P shot UK procedure is not a minor technical detail. It is the central determinant of biological activity at the treatment site. Dual-spin centrifugation produces meaningfully higher platelet concentrations than single-spin methods, delivers more growth factors per injection, and is supported by published comparative evidence.

Men considering PRP-based regenerative therapy for ED in the UK deserve full transparency about the preparation methods used at the clinics they attend. Centrifuge protocol, equipment type, and platelet concentration are not proprietary secrets — they are legitimate clinical disclosures that inform informed consent.

The priapus shot — like any regenerative treatment for male health in the UK — is only as effective as the PRP it delivers. A clinically meaningful penile injection growth intervention begins not at the point of injection, but in the centrifuge.

As PRP science advances and clinicians standardise practices, patients and clinicians continue to ask a key question: should private UK practices disclose the quality of PRP preparation under mandatory standards, just as regulators enforce pharmaceutical manufacturing rules — and if not, what justifies the absence of such disclosure?

Read more: How the Priapus Shot in London Can Improve Your Relationship and Quality of Life

Platelet-Derived Growth Factor in PRP: How It Helps Repair Penile Tissue

P shot London

Most articles on the P shot UK begin with what the treatment does. This one starts where patients should start: with regulation, oversight, and safety standards.

The P shot — also known as the Priapus shot — uses platelet-rich plasma (PRP) derived from the patient’s own blood. The clinician injects it into penile tissue. Proponents cite benefits including improved erectile function and enhanced sensitivity. However, the regulatory environment surrounding this procedure in the United Kingdom is complex and often misunderstood by patients.

Before booking any appointment, patients must understand who regulates this treatment, what standards apply, and what the absence of formal product licensing means in practice. This article addresses all of these questions directly, drawing on NHS guidance, NICE evidence reviews, and peer-reviewed medical literature.

What Is the P Shot and How Is It Administered?

The P shot treatment is a regenerative procedure. A clinician draws a sample of the patient’s venous blood. The blood undergoes centrifugation to concentrate platelets and growth factors. The resulting PRP solution is then injected into targeted areas of the penis using a fine needle.

Growth factors within PRP — including platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF) — stimulate tissue regeneration, improve blood flow, and support neovascularisation. These mechanisms underpin its proposed role as a non-surgical treatment for erectile dysfunction in London and across the UK.

The procedure typically takes 45 to 60 minutes. Topical anaesthetic cream reduces discomfort. Patients generally return to normal activity the same day.

Is the P Shot UK Regulated?

The P shot UK does not hold a product licence from the Medicines and Healthcare products Regulatory Agency (MHRA). PRP is not classified as a medicinal product in the UK. It is categorised as a human tissue-derived product when used autologously — meaning it comes from and returns to the same patient.

This is a critical distinction. It means the P shot is not regulated in the same way as a licensed pharmaceutical drug. However, this does not mean the procedure operates outside all regulatory frameworks.

Who Oversees PRP Procedures in the UK?

Several overlapping regulatory bodies govern practitioners and clinics offering P shot treatment in the UK:

The Care Quality Commission (CQC) regulates providers of healthcare services in England. Clinics offering surgical or invasive procedures — including injections — must be registered with the CQC and adhere to its fundamental standards of care. Patients should verify CQC registration before attending any clinic.

The Human Tissue Authority (HTA) regulates activities involving human tissue in the UK. Autologous PRP — blood taken from and returned to the same patient — falls outside the HTA’s licensing requirements. However, any clinic using allogeneic blood products (from another person) would require HTA oversight.

Professional Medical Regulators such as the General Medical Council (GMC), the Nursing and Midwifery Council (NMC), and the General Pharmaceutical Council (GPhC) regulate individual practitioners. A clinician offering P shot treatment should hold active registration with the relevant body.

The MHRA retains oversight of the centrifugation devices and kits used to prepare PRP. These devices must hold CE marking or UKCA marking to be legally marketed in Great Britain. The quality of the PRP produced depends significantly on the centrifuge system used.

What NICE Says About PRP for Erectile Dysfunction

The National Institute for Health and Care Excellence (NICE) has not issued a formal guideline specifically endorsing PRP injections for erectile dysfunction. NICE guidance on erectile dysfunction (NG226) focuses on pharmacological treatments, lifestyle modification, and vacuum erection devices as first-line interventions.

This does not mean PRP is contraindicated. NICE’s evidence base evolves continuously. The current absence of a NICE recommendation reflects a gap in large-scale randomised controlled trial data — not evidence of harm. Patients should understand this distinction clearly.

The Evidence Base for the Priapus Shot

What Peer-Reviewed Research Shows

Research into PRP-based regenerative therapy for ED is growing but remains in early stages. A 2020 systematic review published in Sexual Medicine Reviews examined available studies on PRP for erectile dysfunction. The review found preliminary evidence suggesting improved erectile function scores following PRP injections. However, the authors noted that most studies were small, lacked control groups, and used varying PRP preparation protocols.

A further study published in the Journal of Sexual Medicine (Epifanova et al., 2020) examined intracavernous PRP injections in men with vasculogenic erectile dysfunction. Participants reported statistically significant improvements in International Index of Erectile Function (IIEF-5) scores at 12-week follow-up.

The evidence supports cautious optimism. It does not support absolute claims of efficacy. Patients considering PRP-based regenerative therapy for ED should approach published outcomes with informed scepticism and request a full evidence discussion with their clinician.

P Shot Before and After — What the Data Actually Shows

Patients frequently search for P shot before and after outcomes online. Clinical photographs and patient testimonials circulate widely on social media. Patients must approach these with caution.

Published P shot before and after data from peer-reviewed sources is limited. Most reported outcomes come from patient satisfaction surveys or uncontrolled observational studies. Improvements in erectile rigidity, sensitivity, and — in some cases — penile dimensions have been reported. However, outcomes vary significantly between individuals.

Factors influencing P shot before and after results include baseline erectile function, vascular health, the quality of PRP preparation, injection technique, and the number of treatment sessions. A single treatment may not produce optimal results. Some protocols recommend two to three sessions spaced several weeks apart.

Patient Safety — What to Check Before Proceeding

Practitioner Qualifications

The P shot UK market is not uniformly regulated. Non-medically qualified individuals have offered injectable treatments in the UK with minimal oversight. The government commissioned the Keogh Review (2013) and subsequent Independent Review of Cosmetic Interventions (2023) specifically to address risks from unregulated aesthetic and injectable treatments.

Patients must confirm that the clinician performing a P shot holds:

• Full GMC registration (verifiable at the GMC website)
• Relevant postgraduate qualifications in aesthetic medicine, urology, or a related surgical discipline
• Evidence of formal training in PRP preparation and penile injection techniques
• Indemnity insurance for the specific procedure

Practitioners with backgrounds in general practice, surgery, or urology are better placed to manage complications and assess patient suitability than those without medical degrees.

Clinic Standards

Patients should confirm the clinic holds CQC registration. They should ask whether the PRP is prepared using a validated, UKCA-marked centrifuge system. They should also confirm the clinic follows infection control standards consistent with NHS guidelines.

The consultation process matters significantly. A reputable clinic will conduct a thorough medical history review, exclude contraindications, and obtain written informed consent. Patients with blood disorders, active infections, or certain medications (including anticoagulants) may not be suitable candidates.

Contraindications and Risk Profile

The P shot carries a low but real risk profile. Documented adverse events in the literature include:

• Temporary bruising or swelling at the injection site
• Mild discomfort during or after injection
• Haematoma formation (rare)
• Infection (rare, typically associated with poor sterile technique)
• No clinically significant improvement (common in cases with severe vascular disease)

Serious complications are rare when the procedure is performed by a qualified clinician in a clinical setting. The risk profile compares favourably with surgical alternatives for erectile dysfunction. Nonetheless, patients should receive a full risk disclosure before proceeding.

How Does the P Shot Compare to Other ED Treatments?

Pharmacological Options

Phosphodiesterase-5 (PDE5) inhibitors — including sildenafil (Viagra) and tadalafil (Cialis) — remain the first-line medical treatment for erectile dysfunction according to NICE guidance. These are MHRA-licensed, evidence-backed, and available via NHS prescription where clinically indicated.

The P shot does not replace pharmacological options. It is typically considered when pharmacological treatments have failed, are contraindicated, or when patients prefer a non-pharmaceutical approach. Some patients use P shot treatment alongside PDE5 inhibitors under medical supervision.

Surgical Interventions

Penile prosthesis implantation remains the most effective surgical intervention for refractory erectile dysfunction. It carries significant surgical risks and requires general anaesthesia. The P shot occupies a distinct clinical space — it is a minimally invasive, regenerative option for patients who are not surgical candidates or who wish to exhaust non-surgical options first.

Other Regenerative Approaches

Low-intensity shockwave therapy (Li-SWT) is another non-surgical treatment for erectile dysfunction in London and across the UK. Like PRP, it stimulates tissue regeneration. Both modalities are under active clinical investigation. Some protocols combine Li-SWT with PRP injections for synergistic effect, though evidence for combination approaches remains preliminary.

The Cost of P Shot Treatment in the UK

What Patients Should Expect to Pay

The priapus shot price in the UK varies considerably depending on the clinic, practitioner qualifications, geographic location, and the number of sessions included in the treatment protocol.

In London, the P shot London price typically ranges from £800 to £2,500 per session. Male enlargement injections cost UK-wide tend to be lower outside London. Multi-session packages may reduce the per-session cost.

Patients should be wary of significantly discounted pricing. Low cost may reflect reduced practitioner qualifications, cheaper PRP preparation kits, or lower clinical standards. The priapus shot price should reflect the quality of the entire clinical pathway — not simply the injection itself.

The NHS does not fund P shot treatment. It is available exclusively through private providers. Patients should request a fully itemised cost breakdown at consultation.

What Patients Should Ask at Consultation

Before proceeding with any P shot UK appointment, patients should ask the following:

Clinician Qualifications :

• What medical qualifications do you hold?
• Are you registered with the GMC or equivalent regulatory body?
• How many P shot procedures have you performed?
• What training have you undertaken in PRP preparation and penile injection?

Procedure Standards:

• Which centrifuge system do you use, and is it UKCA-marked?
• What is the platelet concentration typically achieved?
• How many sessions do you recommend for my specific presentation?
• What outcomes can I realistically expect?

Safety Assurance:

• What are the contraindications and have you reviewed my full medical history?
• What is your protocol if I experience a complication?
• Do you have access to emergency medical support if required?

The Regulatory Reform Landscape

The UK government has committed to strengthening the regulation of non-surgical cosmetic procedures. The Health and Care Act 2022 created powers to introduce a licensing regime for certain aesthetic procedures. The government subsequently confirmed in 2023 that a mandatory licensing scheme would apply to procedures including injectable treatments.

Under these reforms, practitioners offering injectable treatments — which would include penile injections — will require a licence to practice. This represents a significant step towards greater patient protection.

Patients seeking treatment currently should not assume that existing regulatory gaps imply safety. They should apply the same scrutiny to practitioner qualifications and clinic standards that any regulated procedure would demand.

pshots.co.uk and Clinical Governance

Dr Syed Nadeem Abbas at P shots clinic UK — a Harley Street-based clinic in Marylebone, London — offers P shot treatment under a medically supervised protocol. Dr Abbas holds qualifications including MBBS, MRCS (RCS Edinburgh), MRCGP, and an MSc in Aesthetic Plastic Surgery with Distinction from Queen Mary University London, with training at Cambridge, Oxford, and the Royal London Hospital. His clinical background exemplifies the standard of medical governance patients should seek when considering this procedure.

Frequently Asked Questions (FAQ)

Is the P shot legal in the UK?

Yes. The P shot is legal in the UK. It uses the patient’s own blood and is not classified as a medicinal product requiring MHRA licensing. However, the procedure should only be performed by registered medical professionals in CQC-registered premises.

Does the NHS offer the P shot?

No. The P shot is not available on the NHS. It is offered exclusively through private clinics. NHS treatment for erectile dysfunction focuses on PDE5 inhibitors, psychosexual therapy, and — in refractory cases — surgical implants.

How many sessions does the P shot require?

This varies. Some patients report improvement after a single session. Many protocols recommend two to three sessions for optimal outcomes. The treating clinician should tailor the protocol to individual clinical presentation.

Is penile injection growth permanent?

Reported changes in penile dimensions following penile injection growth protocols are typically modest and may not be permanent. The primary clinical application of PRP injections is improvement in erectile function and sensitivity — not structural enlargement. Patients should have realistic expectations clearly established at consultation.

What is the difference between a P shot and a P-shot?

There is no clinical difference. “P shot” and “P-shot” refer to the same procedure. Both terms describe the Priapus shot — a PRP-based injection used as a regenerative treatment for male health in the UK.

Can I combine the P shot with other ED treatments?

In some cases, yes. Combination approaches using P shot treatment alongside Li-SWT or PDE5 inhibitors are used in clinical practice. Patients should discuss combination protocols with their clinician. Not all combinations are appropriate for all patients.

Are P shot results visible immediately?

No. PRP stimulates a biological regenerative process. Results typically develop over four to twelve weeks as growth factors promote tissue repair and angiogenesis. Patients should not expect immediate post-procedure results comparable to pharmaceutical interventions.

Conclusion: Informed Decision-Making in an Uneven Regulatory Environment

The P shot UK occupies a specific position within the regulatory landscape. It is legal, minimally invasive, and supported by preliminary — if not yet conclusive — clinical evidence. It is not, however, a uniformly regulated procedure in the way that licensed pharmaceutical treatments are. This places significant responsibility on patients to scrutinise practitioners, clinics, and clinical protocols before proceeding.

The evidence base for advanced PRP solution for erectile dysfunction continues to develop. Larger, better-controlled studies are needed. Regulatory reforms already underway in the UK will likely improve patient protection in the coming years. In the interim, patients must apply rigorous due diligence.

The core questions remain consistent: Does the practitioner hold GMC registration and appropriate qualifications? Does the clinic maintain CQC registration? Does the PRP preparation system demonstrate clinical validation? Are realistic, evidence-based outcomes communicated at consultation?

Patients who approach this treatment with those questions answered are far better positioned to make genuinely informed decisions.

The broader question worth considering is this: in an era of rapidly evolving regenerative medicine, how should patients balance access to emerging treatments with the caution that an incomplete evidence base demands?

Read more: Understanding the Priapus Shot in London: A Game-Changer for Men’s Sexual Health

P Shot London: How to Choose a Safe Clinic and What to Expect at Your Consultation

P shot London

Most published guidance on the P shot focuses on the procedure itself. It covers the blood draw, centrifugation, platelet concentration, and injection. Far less attention goes to what happens in the weeks and months after treatment. Specifically, very little guidance addresses how a patient’s physiology either supports or undermines the regenerative process.

Platelet-rich plasma (PRP) therapy delivers a concentrated suspension of autologous growth factors directly into penile tissue. These growth factors include platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and transforming growth factor-beta (TGF-β). They initiate angiogenesis, promote collagen remodelling, and stimulate smooth muscle cell proliferation within the corpus cavernosum. However, this process does not occur in isolation. It depends entirely on the body’s internal environment.

Diet, physical activity, sleep quality, hormonal status, and vascular health all shape that internal environment. Together, they determine how effectively injected growth factors produce results. A patient with poor nutritional status, sedentary habits, and disrupted sleep presents a biochemically hostile environment for tissue regeneration. Conversely, a patient who actively supports vascular and endocrine function post-treatment creates conditions in which PRP therapy performs optimally.

This article examines each lifestyle domain in clinical detail. It draws on peer-reviewed evidence and recognised UK sources. The aim is to give men considering or recovering from P shot treatment accurate, evidence-based information — not generic wellness advice.

What the Evidence Says About Lifestyle and Erectile Function

Before examining post-treatment behaviour, it is important to establish why lifestyle factors matter for erectile function at baseline.

NICE acknowledges that erectile dysfunction (ED) shares several risk factors with cardiovascular disease. These include physical inactivity, obesity, smoking, elevated cholesterol, and metabolic syndrome. NICE guidance states that all men with ED should receive counselling on risk reduction and lifestyle modification — particularly exercise and weight loss. This is not peripheral guidance. It reflects the established physiological link between vascular health and erectile function.

NHS Inform states that narrowed blood vessels represent a common cause of erectile dysfunction. Assessment of diet, exercise, and cardiovascular health forms part of the standard clinical evaluation. The British Society for Sexual Medicine (BSSM) similarly positions lifestyle intervention as an integral component of ED management across all treatment modalities.

For men pursuing PRP-based regenerative therapy for ED — whether as a standalone intervention or alongside other treatments — these lifestyle factors carry direct mechanistic relevance to treatment outcome.

Part One: Diet and Nutritional Status

How Diet Influences Endothelial Function and PRP Efficacy

Nitric oxide (NO) is the primary mediator of penile smooth muscle relaxation. Without adequate NO availability, the haemodynamic response required for erection cannot occur effectively. That response includes arterial dilation, cavernosal smooth muscle relaxation, and increased penile blood flow. Peer-reviewed research confirms that poor diet reduces NO bioavailability by impairing endothelial function.

The P shot introduces growth factors that stimulate angiogenesis and new blood vessel formation. This process depends on functional endothelium. A diet chronically high in refined carbohydrates, saturated fats, and ultra-processed foods promotes systemic inflammation and endothelial dysfunction. That creates conditions which reduce the effectiveness of growth factor signalling. Conversely, diets that support endothelial health enhance the vascular substrate on which PRP therapy acts.

Key Dietary Priorities Following P Shot Treatment

Nitrate-rich vegetables: Leafy greens, beetroot, and rocket contain dietary nitrates. The body converts these into nitric oxide via the enterosalivary pathway. These foods directly support endothelial NO production. This facilitates the vascular remodelling that the priapus shot aims to stimulate.

Omega-3 fatty acids: Oily fish — including mackerel, sardines, and salmon — provide omega-3s that reduce systemic inflammation. They lower triglyceride levels and support platelet function. PRP therapy relies on the biological activity of the patient’s own platelets. A diet that maintains healthy platelet function therefore carries direct treatment relevance.

Zinc and magnesium: Both minerals support testosterone synthesis and immune function. Zinc appears in lean red meat, pumpkin seeds, and legumes. Magnesium appears in whole grains, nuts, and dark chocolate. Suboptimal levels of either mineral associate with reduced androgenic function. This in turn may blunt the hormonal environment needed for optimal recovery from penile injection growth procedures.

Antioxidant-dense foods: Berries, tomatoes, green tea, and cruciferous vegetables reduce oxidative stress. Oxidative damage to endothelial cells counteracts the pro-angiogenic effects of VEGF that PRP delivers. Reducing oxidative burden supports the tissue environment in which the priapus shot operates.

Protein adequacy: Tissue repair requires amino acids. Men recovering from P shot treatment should consume adequate dietary protein — approximately 1.2–1.6 g per kilogram of body weight per day. Suitable sources include poultry, fish, eggs, legumes, and low-fat dairy.

What to Avoid

Ultra-processed foods, high-sugar diets, and excessive alcohol all elevate inflammatory markers, impair endothelial function, and reduce testosterone levels. The NHS advises men to limit alcohol to no more than 14 units per week, spread across at least three days. Even moderate excess alcohol consumption reduces vascular responsiveness. This mechanism directly undermines the intended outcomes of non-surgical treatment for erectile dysfunction in London and elsewhere.

Men with type 2 diabetes or metabolic syndrome should note that poor glycaemic control independently predicts impaired erectile function. Tight dietary management of blood glucose therefore carries particular relevance for this group when they pursue an advanced PRP solution for erectile dysfunction.

Part Two: Exercise and Physical Activity

The Mechanistic Role of Exercise in Male Vascular Health

Exercise represents the most evidence-supported lifestyle intervention for erectile dysfunction. A landmark randomised controlled trial demonstrated that obese men assigned to a structured exercise and weight-loss programme achieved clinically meaningful improvement in erectile function scores compared to controls. The mechanism involves improved endothelial function, increased NO bioavailability, reduced inflammatory cytokines, and improved insulin sensitivity. These changes create a more favourable vascular environment.

For men who have undergone P shot treatment, exercise serves an additional function. It maintains and extends the improvements in penile blood flow that the treatment initiates. The P shot promotes angiogenesis — the formation of new blood vessels. Those vessels require adequate perfusion pressure and cardiovascular demand to develop and sustain their function. Regular physical activity provides that stimulus.

Exercise Modalities and Their Relevance

Aerobic cardiovascular exercise: Moderate-intensity aerobic activity has the strongest evidence base for improving erectile function. Brisk walking, cycling, swimming, or rowing — performed for 30–40 minutes at least four times per week — produces meaningful improvements in International Index of Erectile Function (IIEF) scores in men with vasculogenic ED. This finding comes from a systematic review published in Sexual Medicine Reviews.

Published research indicates that exercising at or above 18 metabolic equivalent hours per week associates with improved sexual function. This level of activity corresponds to approximately four to five hours of brisk walking or three hours of moderate jogging per week. Most men can achieve this.

Pelvic floor rehabilitation: A randomised controlled trial published in the British Journal of General Practice found that pelvic floor muscle training significantly outperformed lifestyle advice alone for men with erectile dysfunction. Pelvic floor exercises strengthen the ischiocavernosus and bulbocavernosus muscles. These muscles compress the deep dorsal vein of the penis during erection and contribute to rigidity. Men who track their P shot before and after outcomes and incorporate pelvic floor training consistently report better functional results than those relying on the injection alone.

Resistance training: Progressive resistance exercise increases serum testosterone and growth hormone concentrations acutely and chronically. Testosterone supports penile smooth muscle health and libido. Resistance training two to three times per week, combined with aerobic exercise, provides a comprehensive physiological foundation for PRP therapy for men’s performance issues.

Exercise Timing After Treatment

During the first 48–72 hours following a P shot procedure, men should avoid intense physical activity — particularly anything that increases penile blood pressure or creates friction. The treating clinician will provide specific post-procedure instructions. After this initial period, a graduated return to exercise is appropriate and clinically encouraged.

Part Three: Sleep Quality and Hormonal Regulation

Why Sleep Is a Clinical Variable, Not a Lifestyle Preference

Post-procedure guidance consistently underweights sleep. This is clinically indefensible. Sleep is the primary context in which the body synthesises testosterone. Luteinising hormone (LH) pulses — which stimulate Leydig cell testosterone production — occur predominantly at night. They tie directly to slow-wave sleep architecture. Disrupted sleep impairs this hormonal cascade.

A randomised study published in JAMA found that one week of sleep restriction to five hours per night reduced testosterone levels in young healthy men by up to 15%. A testosterone decline of this magnitude would, over time, meaningfully compromise the tissue-supportive androgenic environment that P shot treatment depends upon.

A large-scale database analysis published in the International Journal of Impotence Research found that men with insomnia had 1.74 times the odds of testosterone deficiency compared to matched controls. Men with circadian rhythm sleep disorders had 2.63 times the odds. These findings confirm that sleep disorders are not merely comorbidities. They actively contribute to the hormonal and vascular dysfunction that ED reflects.

For men investing in P-shot before and after outcomes, protecting sleep quality carries as much clinical weight as the procedure itself.

Sleep, Endothelial Function, and Nitric Oxide

Beyond hormonal effects, sleep quality directly influences endothelial function. A study cited in the International Journal of Impotence Research demonstrated that chronic sleep restriction significantly impairs endothelial function and nitric oxide production. These are the same biological pathways that erectile function relies upon. Nocturnal hypoxemia — commonly associated with obstructive sleep apnoea (OSA) — carries an odds ratio of 1.39 for moderate-to-complete ED in community-dwelling men.

Men who present for men’s intimate health treatment in London and report poor sleep or snoring should undergo OSA assessment. Untreated OSA creates a state of chronic nocturnal hypoxia. It progressively damages the vascular endothelium and renders regenerative penile injection growth procedures less effective.

Evidence-Based Sleep Optimisation

The following measures carry clinical support for improving sleep quality in men:

Maintain a consistent sleep-wake schedule: Irregular sleep timing disrupts circadian rhythm and blunts the nocturnal testosterone surge. Research confirms that circadian rhythm disruption affects both testosterone levels and androgen receptor sensitivity.

Target seven to nine hours per night: Clinical andrology literature consistently identifies this range as optimal for hormonal function. Public Health England frameworks include adequate sleep as part of general health maintenance.

Manage obstructive sleep apnoea: CPAP therapy in men with moderate-to-severe OSA improves erectile function. It does so in part by restoring nocturnal oxygenation and testosterone dynamics.

Reduce pre-sleep screen exposure and alcohol: Both suppress melatonin secretion and fragment slow-wave sleep architecture. This reduces the duration of the most hormonally productive sleep stages.

Part Four: Body Weight, Smoking, and Systemic Inflammation

Obesity and Its Impact on PRP Outcomes

Abdominal obesity independently associates with reduced testosterone, elevated oestrogen, systemic inflammation, and endothelial dysfunction. These factors collectively impair the tissue environment in which PRP-based regenerative therapy for ED operates. Research confirms that only weight loss of 10–15% or more produces clinically meaningful improvements in erectile function in obese men. This makes weight management a priority for this population before and after P shot treatment.

Smoking and Vascular Damage

Smoking causes direct endothelial injury through oxidative stress and impaired NO synthase activity. The NHS advises that smoking is a significant risk factor for ED due to vascular constriction and reduced oxygen delivery to penile tissue. Men who smoke and undergo the P shot create a physiological conflict. The treatment promotes vascular regeneration whilst smoking actively degrades vascular integrity. Smoking cessation represents the single most impactful vascular health intervention available to this group.

Stress, Cortisol, and Hormonal Suppression

Chronic psychological stress elevates cortisol. Elevated cortisol suppresses both testosterone synthesis and hypothalamic-pituitary-gonadal axis activity. Research published in the Asian Journal of Andrology confirms that lifestyle habits which reduce low-grade inflammation improve erectile function. They do so through their effects on NO availability and endocrine status. Men pursuing erectile dysfunction treatment London — whether pharmacological or regenerative — benefit from structured stress management. Evidence-based approaches include cognitive behavioural therapy (CBT) and mindfulness-based stress reduction (MBSR).

What Realistic Outcomes Look Like

Men considering P shot UK treatmentshould approach it with calibrated expectations. A 2024 PLOS ONE meta-analysis of 12 controlled trials involving 991 patients demonstrated that PRP produces statistically significant improvements in IIEF scores compared to placebo. A 2024 systematic review in Translational Andrology and Urology similarly confirmed PRP’s potential in vasculogenic ED. However, researchers consistently note that large-sample, long-follow-up trials are still required to fully characterise the magnitude and duration of benefit.

Results are not uniform. Men with well-controlled vascular risk factors, healthy lifestyle behaviours, and no significant penile fibrosis or severe arterial insufficiency tend to achieve more pronounced P-shot before and after improvements. Men with multiple comorbidities and poor health behaviours achieve less. The priapus shot is a regenerative adjunct, not a curative standalone procedure. Its outcomes reflect the biological environment in which it operates.

At pshots uk clinic , Dr Syed Nadeem Abbas (MBBS, MRCS, MRCGP, MSc Aesthetic Plastic Surgery with Distinction, Queen Mary University London) includes assessment of lifestyle factors as part of every clinical evaluation. This recognises that men asking about male enlargement injections cost UK deserve a broader conversation — one that includes health status and realistic treatment expectations, not just pricing.

Frequently Asked Questions

How soon after P shot treatment should I start exercising?

Men should avoid vigorous physical activity and direct penile contact for 48–72 hours post-procedure. After this period, graduated aerobic exercise is appropriate and encouraged. Full exercise resumption typically follows from 72 hours onwards, subject to clinician guidance.

Does diet affect how long P shot results last?

Yes. The duration of P shot UK results depends on the ongoing health of the vascular and hormonal environment. Men who maintain a diet supporting endothelial function and NO availability — rich in leafy greens, omega-3s, lean protein, and antioxidants — sustain more favourable conditions for growth factors to continue their regenerative effects.

Can poor sleep reduce the effectiveness of the priapus shot London treatment?

Clinically, yes. Sleep deprivation reduces testosterone levels and impairs endothelial function. Both are directly relevant to erectile health. Men with untreated sleep disorders should discuss this with their clinician before or alongside P-shot treatment.

What is the priapus shot price in the UK and does lifestyle affect value for money?

The priapus shot price in the UK varies by clinic and by the number of sessions required. However, any assessment of male enlargement injections cost UK should factor in that lifestyle adherence significantly influences outcome quality. A patient who actively supports vascular health achieves better results. They may also require less frequent repeat sessions. This makes lifestyle modification directly relevant to long-term cost-effectiveness.

Can the P shot replace lifestyle changes for erectile dysfunction?

No. The P shot is a regenerative treatment that works within the body’s existing physiological systems. It does not override them. NICE and NHS guidance consistently position lifestyle modification as a first-line component of ED management. Regenerative and pharmacological treatments perform best when lifestyle factors receive concurrent attention — not as afterthoughts.

Is there an age limit for P shot treatment?

There is no fixed age limit. Clinical assessment of vascular health, comorbidities, medication history, and treatment objectives determines suitability. Men across a wide age range seek non-surgical treatment for erectile dysfunction in London. Clinical evaluation ensures that expectations align with individual physiology.

How many P shot sessions are typically needed?

This varies by patient. Some men report improvement after a single session. Others require two to three sessions spaced several months apart. The treating clinician assesses progress against baseline IIEF scores and adjusts the treatment plan accordingly. Lifestyle factors influence both the degree of improvement per session and the frequency of repeat treatments.

The Bottom Line

The P shot initiates a biological process. It does not complete one. Platelet-rich plasma therapy for men’s performance issues delivers growth factors capable of stimulating angiogenesis, tissue remodelling, and smooth muscle regeneration within the corpus cavernosum. But the effectiveness of that stimulus depends entirely on the physiological environment the patient maintains before, during, and after treatment.

Diet influences endothelial function and nitric oxide availability — the vascular substrate on which the treatment acts. Exercise maintains and extends the improvements in penile blood flow that the priapus shot promotes. Sleep preserves testosterone synthesis and endothelial integrity — both of which are mechanistically central to erectile function and recovery. Smoking, obesity, and chronic stress actively counteract each of these mechanisms.

The evidence from NICE, NHS guidance, and peer-reviewed literature converges on a consistent conclusion. Lifestyle is not ancillary to erectile function treatment — it is integral to it. Men who approach the P shot as part of a broader commitment to vascular and hormonal health achieve better outcomes than those who treat it as an isolated intervention.

The relevant clinical question, therefore, is not simply whether PRP therapy for men’s performance issues suits a given patient. The more informative question is this: what biological environment is that patient currently providing for regenerative treatment — and what are they willing to change?

Read more: How the Priapus Shot in London Can Improve Your Relationship and Quality of Life

P Shot London: What Men with Diabetes Need to Know About Erectile Dysfunction Treatment

P shot London

Platelet-rich plasma (PRP) contains a concentrated mixture of bioactive proteins. Among these, platelet-derived growth factor (PDGF) plays a particularly significant role in tissue repair, cellular signalling, and vascular remodelling. In the context of male sexual health, understanding how these molecular mechanisms operate helps clinicians and patients make better-informed decisions about regenerative treatment options such as the P shot (Priapus shot).

This article presents the current scientific evidence regarding how platelet-derived growth factor and related proteins within PRP interact with penile tissue at a cellular level. It also outlines what the existing clinical literature supports — and where the evidence remains limited.

What Is Platelet-Derived Growth Factor and Why Does It Matter in Penile Tissue?

The Molecular Origin of PDGF

Platelet-derived growth factor is a dimeric glycoprotein that platelets store within their alpha-granules. It exists in four isoforms: PDGF-AA, PDGF-AB, PDGF-BB, and PDGF-CC. Each isoform binds to specific receptor tyrosine kinases — primarily PDGFRα and PDGFRβ — thereby triggering downstream cellular signalling cascades.

When platelets activate following tissue injury or therapeutic injection, they degranulate. This process releases PDGF alongside vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGF-β), epidermal growth factor (EGF), insulin-like growth factor (IGF-1), and fibroblast growth factor (FGF). Together, these proteins coordinate the biological response to injury and regeneration.

Why Penile Tissue Requires Specific Repair Mechanisms

The penis contains a complex microarchitecture. The corpora cavernosa consist of smooth muscle cells, endothelial cells, connective tissue, and a dense vascular network. Erectile function depends on the integrity of these structures.

Conditions such as erectile dysfunction (ED), Peyronie’s disease, and age-related tissue fibrosis disrupt this architecture in specific ways. Researchers have well-documented smooth muscle cell loss, endothelial dysfunction, and collagen dysregulation as key contributors to impaired erectile function, as noted in peer-reviewed urological literature published in the International Journal of Impotence Research (Israeli et al., 2022, PMC9072597).

The Science of PRP: Preparation, Composition, and Concentration

How PRP Is Prepared

Clinicians produce PRP by centrifuging a patient’s venous blood sample. The centrifuge separates blood into three layers: red blood cells settle at the base, a buffy coat layer containing concentrated platelets and white blood cells forms in the middle, and platelet-poor plasma rises to the top.

The clinician then collects the buffy coat and surrounding plasma. This produces a solution with a platelet concentration typically 2 to 8 times greater than whole blood. Consequently, the concentration of platelet-derived growth factor in the final preparation increases correspondingly.

Variability in PRP Preparations

PRP is not a standardised pharmaceutical product. Platelet concentration, activation method, and white blood cell content differ significantly across preparation protocols and commercial systems. Furthermore, this variability directly affects the concentration of platelet-derived growth factor and other bioactive proteins in the final injection.

Currently, NICE (National Institute for Health and Care Excellence) does not endorse a single PRP preparation standard for urological applications. As a result, this lack of standardisation remains a recognised limitation in the existing evidence base.

How Platelet-Derived Growth Factor Acts on Penile Tissue

Smooth Muscle Cell Proliferation and Preservation

Smooth muscle cells within the corpora cavernosa regulate penile haemodynamics during erection. Their loss or replacement by fibrotic tissue reduces erectile capacity. Notably, PDGF-BB in particular has demonstrated the ability to promote smooth muscle cell proliferation in laboratory models.

Receptor binding of platelet-derived growth factor initiates a phosphorylation cascade involving phospholipase C, PI3K, and MAP kinase pathways. These pathways then regulate cell division, survival, and migration. In penile tissue models, this consequently translates to potential preservation and replenishment of functional smooth muscle cells.

Endothelial Cell Activation and Angiogenesis

VEGF, which platelets co-release alongside platelet-derived growth factor during degranulation, directly stimulates endothelial cell proliferation and new blood vessel formation. In addition, PDGF contributes to vessel stabilisation by recruiting pericytes to newly formed capillaries.

This dual-action mechanism — VEGF initiating angiogenesis and PDGF stabilising the vascular network — is well-established in wound healing literature. Furthermore, it forms the theoretical basis for PRP’s potential role in improving penile vascular integrity.

Fibrosis Reduction and Collagen Remodelling

TGF-β, another co-released growth factor, participates in collagen synthesis and extracellular matrix remodelling. In conditions such as Peyronie’s disease, aberrant collagen deposition creates fibrotic plaques within the tunica albuginea. The interaction between platelet-derived growth factor and TGF-β signalling pathways may therefore modulate the balance between fibrosis and normal tissue repair.

Pre-clinical studies have shown that PRP injection in animal models reduces fibrotic tissue area and preserves structural integrity of penile tissue. However, these findings require validation through robust human clinical trials before researchers can draw definitive conclusions.

Neuroprotection and Nerve Regeneration

IGF-1, released alongside platelet-derived growth factor, supports Schwann cell function and peripheral nerve regeneration. Nerve damage — particularly following prostatectomy — commonly contributes to post-surgical erectile dysfunction. The potential neuroprotective effects of PRP in this context represent an active area of pre-clinical research, though clinical evidence currently remains preliminary.

Clinical Evidence for the P Shot in Men’s Health

What the Published Literature Supports

The P shot (also referred to as the Priapus shot or pshot) involves injecting autologous PRP directly into the penile shaft and glans. The procedure aims to deliver concentrated platelet-derived growth factor and associated proteins to the target tissue.

A systematic review published in the International Journal of Impotence Research (Israeli et al., 2021) examined available studies on PRP for penile conditions. Researchers identified early positive signals in small-scale trials for mild to moderate erectile dysfunction. However, they also noted that most studies involved small sample sizes, lacked control groups, and used inconsistent PRP preparation methods.

For Peyronie’s disease, early studies suggest that penile injection with PRP — sometimes in combination with other treatments — may reduce plaque size and curvature. Again, the evidence base remains early-stage and heterogeneous.

What the Evidence Does Not Yet Support

Current published evidence does not support the use of P shot treatment as a first-line, evidence-based intervention for erectile dysfunction. Moreover, NHS guidance and NICE recommendations do not currently include PRP-based therapies for ED or Peyronie’s disease within their standard treatment pathways.

Claims regarding permanent penile enlargement, guaranteed restoration of erectile function, or quantified improvements in sexual performance lack support in the available peer-reviewed literature. Clinicians and patients should therefore treat such claims with appropriate caution.

P Shot Before and After: Managing Expectations

Reports of P shot before and after outcomes in the clinical literature describe variable results. Some participants in small trials report improved erectile rigidity and sensation. Others, by contrast, report no subjective change. Currently, no validated clinical tool exists that is specifically designed to assess P shot before and after outcomes consistently across trials.

Realistic expectations include the possibility of modest improvement in erectile quality in selected patients with mild dysfunction, alongside the genuine possibility of no measurable benefit. Adverse effects in the literature include transient bruising, localised swelling, and mild discomfort at the injection site. Serious adverse events are uncommon.

Who May Be Considered for PRP-Based Penile Therapy

Patient Selection Criteria in Current Research

Published studies have focused primarily on men with mild to moderate organic erectile dysfunction who have not responded adequately to phosphodiesterase-5 inhibitors (PDE5i) such as sildenafil, or who prefer non-pharmacological approaches. In addition, men with post-prostatectomy ED represent another subgroup that preliminary trials have studied.

Men with Peyronie’s disease — particularly in the active, inflammatory phase — have also featured in early clinical trials, with some reporting reduction in plaque-associated pain.

Contraindications and Caution

PRP therapy uses the patient’s own blood, which minimises immunogenic risk. However, clinicians must avoid it in patients with platelet dysfunction disorders, active infection at the injection site, haematological malignancies, or those taking anticoagulant therapy without medical clearance.

Furthermore, clinicians offering non-surgical treatment for erectile dysfunction in London or elsewhere in the UK must conduct thorough medical assessment prior to any PRP-based procedure.

PRP as Part of a Broader Therapeutic Framework

Integration with Established Treatments

PRP-based regenerative therapy for ED does not replace established medical treatments. PDE5 inhibitors remain the first-line pharmacological option that NHS guidelines endorse. Vacuum erection devices, penile prostheses, and psychological interventions also form part of the evidence-based management pathway.

Consequently, advanced PRP solution for erectile dysfunction more appropriately serves as a potential adjunct — or an option for patients who have exhausted other avenues — rather than a primary standalone treatment. Men’s intimate health treatment in London increasingly incorporates multimodal approaches that combine lifestyle modification, pharmacotherapy, and emerging regenerative options within a supervised clinical framework.

The Role of Platelet-Derived Growth Factor in Regenerative Medicine Broadly

Platelet-derived growth factor holds established roles in orthopaedic, dermatological, and wound healing applications. Its use in tendon repair, bone regeneration, and chronic wound management draws on a more extensive evidence base than currently exists for urological applications. Nevertheless, this broader body of evidence provides the biological rationale for investigating its application in penile tissue repair, even as urological-specific clinical evidence continues to develop.

Cost, Access, and the UK Regulatory Context

Male Enlargement Injections Cost UK: What Patients Should Know

PRP-based penile injections — marketed variously as the P shot UK, priapus shot London, Priapus shot, or penis shot — are not available on the NHS. Instead, private clinics exclusively offer these treatments.

The priapus shot price varies across providers. In London, costs typically range from £500 to £1,500 per session depending on clinic, practitioner experience, and preparation protocol. Some clinics offer package pricing for multiple sessions. Patients should therefore request transparency regarding the PRP preparation method, platelet concentration targets, and the practitioner’s qualifications before proceeding.

Male enlargement injections cost UK varies significantly. Price alone does not reliably indicate quality. Patients should consequently prioritise clinical credentials and evidence-based consultation over promotional pricing.

Regulatory Status in the UK

PRP is a minimally invasive medical procedure in the UK. It is not a licensed medicinal product. Clinics offering PRP therapy for men’s performance issues operate under general clinical governance frameworks, including Care Quality Commission (CQC) registration requirements for certain types of medical facilities.

Patients seeking PRP-based regenerative therapy for ED in the UK should therefore verify that their treating clinician holds appropriate medical registration with the General Medical Council (GMC) and relevant specialist training.

Dr Syed Nadeem Abbas at P shots UK clinic, based in Wimpole Street, Marylebone, London, holds MBBS, MRCS RCS Edinburgh, MRCGP, and an MSc in Aesthetic Plastic Surgery with Distinction from Queen Mary University London, with training at Cambridge, Oxford, and the Royal London Hospital.

Frequently Asked Questions (FAQ)

What is the difference between PRP and platelet-derived growth factor?

PRP (platelet-rich plasma) is the biological preparation — a concentrated plasma fraction containing elevated levels of platelets. Platelet-derived growth factor (PDGF) is one of several specific proteins that those platelets release when they activate. PDGF is therefore a component within PRP, not synonymous with it.

How many P shot sessions are typically needed?

The published literature does not establish a standard treatment protocol. Studies have used single injections as well as series of three or more sessions over several months. Consequently, the appropriate number of sessions depends on individual clinical assessment.

Is the P shot painful?

Clinicians apply a topical anaesthetic cream and/or local anaesthetic injection prior to the procedure. Most patients report mild to moderate discomfort. The procedure typically takes under 30 minutes.

Does the P shot permanently increase penile size?

No peer-reviewed clinical evidence supports permanent penile enlargement as a reliable or consistent outcome of PRP injection. Clinicians making such claims without supporting evidence are not adhering to evidence-based practice standards.

How long does it take to see results from a P shot?

In trials reporting positive outcomes, participants noted changes over a period of weeks to months. Individual variability is significant. Furthermore, some participants in published studies reported no change at all. Outcomes are not guaranteed.

Are there any natural ED treatment options using PRP therapy that the NHS recommends?

The NHS does not currently recommend natural ED treatment using PRP therapy as part of its standard clinical pathway. Instead, lifestyle modifications — including weight management, smoking cessation, cardiovascular exercise, and alcohol reduction — form the evidence-based foundation of natural ED management.

Is the P shot safe?

Adverse events in clinical studies are generally mild and transient, including localised bruising, swelling, and temporary discomfort. Because PRP uses the patient’s own blood, the risk of allergic reaction or infection is low, though not zero. Serious adverse events are rare but possible in any invasive procedure.

Key Takeaways

The biological mechanisms through which platelet-derived growth factor may influence penile tissue repair are scientifically coherent. PDGF’s roles in smooth muscle cell proliferation, vascular stabilisation, and modulation of collagen remodelling provide a rational basis for investigating PRP therapy in male sexual health.

However, the current clinical evidence for the P shot — whether referred to as P-shot, penile injection growth, p injection, or priapus shot — remains preliminary. Small sample sizes, inconsistent PRP preparation methods, absence of standardised outcome measures, and limited long-term follow-up data mean that researchers cannot yet draw definitive efficacy conclusions.

Patients considering this treatment should therefore engage with fully qualified medical practitioners, review the available evidence critically, and maintain realistic expectations. The science of platelet-derived growth factor in regenerative medicine continues to advance, and the urological application of PRP warrants rigorous, large-scale clinical investigation.

Ultimately, the most important question for any patient considering this treatment is not whether the biological mechanism is plausible — it is — but whether the available clinical evidence sufficiently justifies the procedure for their specific situation. That question deserves an honest, evidence-based answer from a qualified clinician.

Read more: Understanding the Priapus Shot in London: A Game-Changer for Men’s Sexual Health

P Shot London: How to Choose a Safe Clinic and What to Expect at Your Consultation

P shot London

Platelet-rich plasma (PRP) therapy applied to penile tissue — commercially termed the Priapus shot or P-shot — is now available at multiple private clinics across the United Kingdom. Yet clinics publish pricing inconsistently, and many prospective patients arrive at consultations without a clear understanding of what drives cost variation, what a quoted fee includes, or what the evidence base actually supports.

This article sets out the factual pricing landscape for P-shot treatment in the UK. It explains the clinical and logistical variables that determine cost, outlines what a well-structured treatment pathway should include, and identifies the limitations and realistic outcomes that any evidence-informed patient should understand before committing financially.

What Is the Priapus Shot?

The Priapus shot — also written as P-shot or Pshot — is an autologous PRP procedure. A clinician draws a sample of the patient’s own blood, processes it in a medical-grade centrifuge to concentrate the platelet-rich plasma, and then injects it into specific anatomical sites within the penis: typically the glans and corpus cavernosum.

The theoretical mechanism centres on growth factors contained within activated platelets — including platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and transforming growth factor-beta (TGF-β). These growth factors promote angiogenesis, smooth muscle regeneration, and neural tissue repair — all directly relevant to erectile physiology.

The term “Priapus Shot” and its abbreviation “P-Shot” are registered trademarks. UK providers deliver this procedure under various names — penile PRP injection, penile injection growth therapy, or P injection — though the core biological mechanism remains consistent across providers who use standardised PRP preparation protocols.

The Evidence Base: What UK Clinical Sources State

It is important to be direct about the state of the evidence. NICE does not currently approve the P-shot as a standard treatment for erectile dysfunction (ED). The NHS does not fund this procedure. It falls under the category of regenerative medicine delivered within the private sector.

Peer-reviewed studies have examined PRP for ED. A randomised controlled trial by Matz et al. (2018), published in the Journal of Sexual Medicine, found statistically significant improvements in erectile function scores in treated patients compared to placebo. A systematic review by Dołżan et al. (2022) concluded that PRP therapy showed promise for mild-to-moderate vasculogenic ED, though the authors noted that larger, longer-term trials are needed before clinicians can establish definitive guidelines.

For Peyronie’s disease — a condition involving penile curvature secondary to fibrotic plaque formation — a 2021 study in Translational Andrology and Urology reported measurable reductions in plaque size and curvature following intralesional PRP injection. Again, sample sizes remain modest.

Patients should interpret these findings carefully. The procedure shows early clinical promise, but it does not carry the same evidentiary weight as established ED treatments such as phosphodiesterase-5 inhibitors (e.g., sildenafil, tadalafil). NICE guideline NG225 endorses those treatments, backed by extensive randomised controlled trial data.

P-Shot UK Price: What the Market Currently Reflects

Typical Price Ranges in the UK

P shot UK price varies considerably across clinics. Current market data reflects the following ranges:

• Standard single P-shot session: £900 – £1,500
• P-shot combined with additional modalities (e.g., botulinum toxin, shockwave therapy): £1250 – £2,500
• Multi-session treatment packages: £2,000 – £4,000+
• London Harley Street and central London clinics: typically at the upper end of these ranges

These figures represent starting prices. Clinics confirm the final cost only after a medical consultation that establishes diagnosis, treatment suitability, and the specific protocol required.

Clinics in Kent, the Midlands, or the North of England may offer pricing closer to £900–£1,100 for a standard session. London-based providers — particularly those operating on Harley Street or in the W1 postcode — typically charge £800–£1,500 or above for a comparable procedure. This reflects overhead, clinic grade, and practitioner seniority.

What Drives P-Shot Price Variation in the UK?

1. PRP Preparation Quality

Not all PRP is equivalent. The concentration of platelets in the final injectate varies significantly depending on the centrifuge system. Medical-grade systems cleared for clinical use — such as those compliant with EU In Vitro Diagnostic Directive standards — produce more consistent and concentrated preparations than entry-level alternatives.

Higher platelet concentration directly influences therapeutic potential. A clinic using a validated, high-yield centrifuge system will typically charge more than one using a lower-specification device. When you compare priapus shot prices between providers, the equipment used is one of the most clinically meaningful differentiators — not simply the volume of plasma injected.

2. Practitioner Qualifications and Clinical Setting

In the UK, a registered medical professional — typically a doctor registered with the General Medical Council (GMC) — should perform PRP penile injections. The procedure involves injecting into sensitive anatomical structures, requires topical or local anaesthetic, and demands a thorough pre-procedure assessment covering relevant medical history, current medications, and contraindications.

Practitioners with postgraduate surgical or aesthetic qualifications, or those working in CQC-registered facilities, carry a higher compliance overhead. Pricing appropriately reflects this.

Clinics offering P shot London pricing significantly below £900 for an apparently equivalent procedure warrant careful scrutiny — specifically regarding equipment standards, practitioner credentials, and whether a proper pre-procedure consultation is included.

3. Whether the Consultation Fee Is Included

Some clinics quote a headline price that excludes the consultation, which they may charge separately at £100–£250. Others include this within a treatment package. When comparing P-shot UK prices across providers, confirm exactly what the quoted figure covers.

A proper medical consultation for this procedure should cover: medical history review, discussion of the underlying causes of ED or the specific condition being treated, physical examination where clinically relevant, a discussion of realistic outcomes, and written consent.

4. Additional Treatments or Adjuncts

Many clinics now offer the P-shot as part of a combined protocol. These may include:

• Bocox (botulinum toxin penile injection): Botulinum toxin injected into the corpus cavernosum to relax smooth muscle and improve arterial inflow
• Extracorporeal shockwave therapy (ESWT): Low-intensity shockwave applied to penile tissue to stimulate neovascularisation
• Penile vacuum pump protocols: Used post-procedure to encourage tissue expansion alongside PRP-stimulated growth

Each adjunct adds to overall cost. Combined protocols sometimes offer better value per modality when bundled, but they also represent a higher total financial commitment.

5. Number of Sessions Required

A single P-shot session is sufficient for some patients. Others — particularly those with more established vasculogenic ED, Peyronie’s disease with significant plaque, or Lichen Sclerosus — may require a course of two to three sessions spaced eight to twelve weeks apart.

The total cost of a full treatment course can therefore reach two to three times the single-session price. Clinics should provide clear guidance on the likely number of sessions before treatment commences.

P-Shot Before and After: Realistic Expectations

One of the most common information gaps on clinic websites is an honest, evidence-grounded account of what patients should and should not expect from P-shot treatment. Clarity here matters.

What the Evidence Suggests May Improve

Based on published peer-reviewed literature:

• Erectile function scores: Studies using validated tools (IIEF-5) show statistically significant improvement in mild-to-moderate vasculogenic ED
• Penile sensitivity: Some patients report improved sensory response, though the current literature offers limited objective measurement of this outcome
• Peyronie’s plaque: Pilot studies report reductions in plaque volume and degree of curvature
• Lichen Sclerosus: Early studies show PRP has immunomodulatory effects for this autoimmune condition

What Current Evidence Does Not Support

• Guaranteed or predictable size increase without vaccum device use
• Resolution of severe vasculogenic ED where arterial disease is advanced
• Permanent reversal of neurogenic ED caused by radical prostatectomy or significant spinal pathology
• A cure for underlying hormonal causes of ED without addressing those causes directly

P shot before and after outcomes depend substantially on baseline health status, the underlying aetiology of ED, age, cardiovascular fitness, and adherence to adjunct protocols such as vacuum device use. Clinics presenting dramatic before-and-after claims without these contextual caveats are not providing balanced information.

Male Enlargement Injections Cost UK: A Specific Note

Some patients seek penile PRP injections primarily for size-related concerns rather than erectile dysfunction. This is a distinct use case from therapeutic ED management and warrants separate discussion.

The evidence for PRP as a standalone male enlargement injection is limited. Studies that attribute size increases to P-shot treatment consistently involve concurrent use of a penile vacuum pump. The vacuum device applies mechanical traction to promote tissue expansion during the period of PRP-stimulated cellular proliferation. Without consistent use of the vacuum device, size outcomes become considerably less predictable.

The cost of penile injection growth procedures marketed specifically for enlargement follows similar pricing to standard P-shot treatment — £800 to £1,500 per session — though some providers charge a premium for enhancement-focused protocols.

Patients considering this primarily for size reasons should receive clear counselling on the evidence limitations, realistic outcomes, and the central role of adjunct device use.

What a Properly Structured P-Shot Consultation Should Include

A thorough medical consultation prior to P-shot treatment in London or elsewhere in the UK should address the following:

• Medical history: Cardiovascular status, diabetes, haematological disorders, current anticoagulant use, history of prostate cancer treatment, neurological conditions
• Examination: Assessment of penile anatomy, presence of plaques, baseline erectile function using a validated questionnaire such as the IIEF-5
• Contraindications: Active infection, bleeding disorders, active malignancy, use of anticoagulants that cannot be temporarily paused
• Informed consent: Written documentation covering the procedure, risks (including pain, bruising, haematoma, and rare infection), realistic outcome range, and likely number of treatment sessions
• Follow-up: A defined follow-up appointment, typically at six to twelve weeks post-procedure, to assess response and discuss further management

Any clinic that does not provide this structure — whether for a Priapus shot London appointment or elsewhere in the UK — falls below the standard that responsible private medical practice requires.

Priapus Shot London: What a Harley Street Standard Should Reflect

London-based P-shot clinics at the Harley Street level operate within a well-established private medical infrastructure. Patients attending at this level should expect CQC-registered premises, GMC-registered practitioners, medical-grade equipment, and a full clinical governance framework.

P shots UK clinic is one such provider, led by Dr Syed Nadeem Abbas (MBBS, MRCS RCS Edinburgh, MRCGP, MSc Aesthetic Plastic Surgery with Distinction — Queen Mary University London). Dr Abbas holds surgical and aesthetic postgraduate training across Cambridge, Oxford, and the Royal London Hospital — a background directly relevant to a procedure that requires anatomical precision and robust clinical assessment.

The pricing at Harley Street clinics reflects central London overheads, but also the quality of the clinical pathway: the consultation depth, equipment specification, practitioner seniority, and post-treatment follow-up structure. These are meaningful clinical differentiators, not merely cosmetic ones.

Finance and Payment Options for P-Shot Treatment UK

A single P-shot session typically costs £1250–£1,500, and a full course may total £2,000–£4,000 or more. Many UK clinics now offer finance options — typically 0% interest instalment plans arranged through regulated consumer credit providers.

Any finance agreement for medical treatment in the UK falls under Financial Conduct Authority (FCA) regulation via the Consumer Credit Act. Clinics offering 0% finance must hold authorisation or act as credit brokers through an authorised lender. Patients have the right to receive a full credit agreement in writing before signing.

Finance does not change the clinical calculus — it simply addresses affordability. Base your treatment decision on clinical suitability and realistic outcome expectations, then consider finance as a secondary practicality.

Frequently Asked Questions

Is the P-shot available on the NHS?

No. The P-shot is a private medical procedure. The NHS does not fund it, and NICE has not approved it as a standard treatment for erectile dysfunction or Peyronie’s disease.

How much does the P-shot cost in London?

P-shot London pricing typically starts from £800 and can reach £1,500 or above for a single session at an established Harley Street clinic. Combined protocols that include additional modalities cost more.

How many P-shot sessions will I need?

This depends on the underlying condition. Mild ED in otherwise healthy men may respond to a single session. Peyronie’s disease, Lichen Sclerosus, or more advanced ED typically requires two or three sessions. Your clinician should give you an honest estimate of likely session numbers at consultation.

Does the P-shot hurt? 

Clinicians perform the procedure under topical anaesthetic cream applied to the penis. Most patients report minimal discomfort during the injection itself. Some experience temporary soreness or bruising at the injection sites for one to three days post-procedure.

What is the recovery time after a P-shot?

 There is no significant clinical downtime. Patients can typically return to work the same day. Clinics generally advise avoiding sexual activity for 24–48 hours post-procedure, though specific guidance varies by provider.

Are there any risks or side effects?

 As with any injection procedure, risks include localised bruising, swelling, temporary discomfort, and a small risk of infection. Serious adverse events are rare when a qualified medical practitioner performs the procedure using sterile technique. Allergic reactions to PRP do not apply, as the preparation derives from the patient’s own blood.

Can the P-shot help with Peyronie’s disease? 

Early clinical evidence supports the use of intralesional PRP for Peyronie’s disease, specifically showing reductions in curvature and plaque size. However, this is not a licensed treatment in the UK, and results vary. A full clinical assessment is required before a clinician can recommend this use case.

Will the P-shot increase penis size? 

Robust clinical evidence does not support predictable size increase using PRP alone. Studies reporting size gains consistently involve concurrent use of a penile vacuum pump. Patients should receive clear counselling on this point before committing to treatment.

Is the P-shot safe for men on blood thinners? 

Anticoagulant use is a relative contraindication. Clinicians can temporarily pause some anticoagulants before the procedure under medical supervision — discuss this with both the treating clinician and the prescribing physician. Patients on anticoagulants for high-risk cardiovascular or thromboembolic conditions should approach this decision with particular care.

How long do P-shot results last? 

Published studies and clinical observation suggest results last between six and eighteen months. Individual variation is significant. Patients with well-controlled cardiovascular risk factors and good baseline health tend to maintain results longer. Repeat sessions are often necessary to sustain benefit.

key takeaways

The priapus shot price in the UK reflects a genuine set of clinical and operational variables: the quality of PRP preparation, the qualifications of the practitioner, the depth of the consultation, the clinical setting, and whether adjunct treatments are included. Price alone is not a reliable proxy for quality. Low pricing in this category may indicate compromised clinical standards.

The P-shot is a legitimate private medical procedure with an emerging — but not yet conclusive — evidence base. It suits men with mild-to-moderate vasculogenic ED, Peyronie’s disease, or Lichen Sclerosus who have undergone thorough medical assessment and hold realistic expectations of outcome. It does not substitute for addressing underlying cardiovascular or hormonal causes of erectile dysfunction, and it carries neither NICE endorsement nor NHS funding.

For any man considering P-shot UK treatment, the most important investment is not in the procedure itself, but in the quality of the clinical assessment that precedes it. A practitioner who explains both what the treatment can and cannot achieve — and who structures a pricing model around genuine clinical value — is the one most likely to deliver a safe and worthwhile outcome.

The question worth sitting with before booking is this: have you received enough clinical information to make a truly informed decision, or are you still filling in the gaps with marketing language?

Read more:

P Shot London: How to Choose a Safe Clinic and What to Expect at Your Consultation

Understanding the Priapus Shot in London: A Game-Changer for Men’s Sexual Health

P shot London

Two non-surgical options attract increasing interest from men in London seeking penile enhancement and sexual health improvement: the P Shot (Priapus Shot) and hyaluronic acid (HA) penile fillers. Both fall under the broader category of non-surgical penile enhancement in London, but they work through entirely different biological mechanisms, carry different evidence bases, and produce distinct clinical outcomes.

When comparing P Shot vs Hyaluronic Acid Penile Fillers in London, patients must understand precisely what each procedure involves, what realistic results look like, and what the current clinical literature says. Therefore, this article provides a structured, evidence-based comparison to support informed decision-making.

What Is the P Shot (Priapus Shot)?

The P Shot — short for Priapus Shot — is a PRP (platelet-rich plasma) penile treatment. It uses the patient’s own blood to deliver concentrated growth factors directly into penile tissue.

How the P Shot Procedure Works

A clinician draws a small volume of the patient’s blood — typically 20–30 ml — and places it in a centrifuge. This process separates the blood into its components, isolating the platelet-rich plasma. The clinician then injects the PRP into specific areas of the penis, including the corpus cavernosum and the glans.

The platelets in PRP contain a range of growth factors, including platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and transforming growth factor beta (TGF-β). Crucially, these signalling proteins stimulate tissue repair, neovascularisation, and cellular regeneration — all of which occur gradually over several weeks.

What the P Shot Is Designed to Address

The P Shot treatment primarily targets:

•        Erectile dysfunction (ED), including cases associated with Peyronie’s disease

•        Reduced penile sensitivity

•        General sexual performance concerns

•        Penile rehabilitation following surgery or radiation therapy

The P Shot is often chosen by London patients to improve erection quality, increase sensitivity, and sometimes achieve small gains in size. However, results vary considerably between individuals, and clinicians must set realistic expectations during consultation.

Evidence Base for the Priapus Shot

Research into PRP penile treatment vs fillers shows that PRP therapy carries more published clinical data related to erectile function than it does for purely cosmetic enlargement. Specifically, a 2021 review published in Sexual Medicine Reviews found that intracavernous PRP injections showed promise in improving erectile function scores. Nevertheless, the authors called for larger randomised controlled trials before bodies such as NICE could recommend PRP as a first-line treatment.

Furthermore, a study in the International Journal of Impotence Research (Matz et al., 2018) reported significant improvement in International Index of Erectile Function (IIEF) scores in men who received PRP injections compared to controls. That said, the sample sizes were small and follow-up periods varied considerably.

Important: The MHRA does not currently approve the P Shot as a licensed treatment for erectile dysfunction. Clinicians who offer the Priapus Shot London must ensure patients receive a thorough consultation, and they must deliver treatment within an appropriate clinical governance framework.

What Are Hyaluronic Acid Penile Fillers?

Hyaluronic acid penile fillers are injectable dermal fillers — the same class of product used in facial aesthetics — adapted for penile girth enlargement. The procedure adds cross-linked hyaluronic acid beneath the penile skin to increase circumference.

How the Penis Filler Procedure Works

Clinicians perform the penis filler procedure under topical or local anaesthesia. They inject a cross-linked HA gel into the subcutaneous tissue of the penile shaft, typically using a cannula rather than a needle to reduce the risk of intravascular injection. The filler integrates with surrounding tissue and increases penile girth immediately.

Hyaluronic acid is a naturally occurring polysaccharide found in connective tissue. Cross-linked HA resists enzymatic degradation and consequently remains in tissue longer than non-cross-linked forms. Depending on the product and volume used, results last between 12 and 24 months before the filler gradually absorbs.

What HA Penile Fillers Are Designed to Address

Clinicians consider penile girth enhancement with HA fillers a cosmetic procedure. It primarily addresses:

•        Penile girth enlargement (circumference, not length)

•        Glans augmentation

•        Penile dysmorphic concerns where surgical intervention is not warranted

Penis filler London and UK clinics offer this as a non-surgical alternative to penis enlargement surgery UK. Importantly, it does not replicate the functional outcomes of the P Shot — it does not improve erectile function, blood flow, or penile sensitivity.

Evidence Base for Hyaluronic Acid Penile Fillers

The evidence base for HA penile fillers UK continues to grow, though — like the P Shot — it lacks the large randomised controlled trials necessary for formal NICE endorsement. In 2019, a systematic review in the Journal of Sexual Medicine (Littara et al.) reported that HA penile fillers produced statistically significant increases in flaccid and erect penile circumference, with high patient satisfaction rates and a manageable adverse event profile when experienced practitioners performed the procedure.

Additionally, the British Association of Aesthetic Plastic Surgeons (BAAPS) does not formally endorse penile filler procedures as of 2024. BAAPS notes that they fall outside the scope of standard reconstructive urology. Consequently, patients considering penile girth enhancement options UK must ensure a medically qualified practitioner with specific training carries out the procedure.

P Shot vs Hyaluronic Acid Penile Fillers London: Side-by-Side Comparison

The table below summarises the key clinical and procedural differences between the P Shot and HA penile fillers.

Feature	P Shot (Priapus Shot)	Hyalurnic Acid Penile Fillers
Primary mechanism	PRP growth factors stimulate tissue regeneration	HA gel increases subcutaneous tissue volume
Primary purpose	Erectile function, sensitivity, tissue repair	Penile girth enlargement (cosmetic)
Material used	Patient’s own blood (autologous)	Synthetic cross-linked hyaluronic acid
Immediate cosmetic change	Minimal to none	Immediate increase in girth
Functional improvement	Possible improvement in erectile quality	No direct effect on erectile function
Duration of results	Variable; may be long-lasting if regeneration occurs	12–24 months (filler is reabsorbable)
Reversibility	Not reversible (biological process)	Partially reversible with hyaluronidase
Risk of allergic reaction	Very low (autologous)	Low, but possible
Evidence quality	Small RCTs; promising but limited	Observational studies; growing evidence
MHRA licensed?	No	HA fillers are CE/UKCA marked devices
Suitable for ED?	Yes (primary indication)	No
Suitable for girth enlargement?	Limited cosmetic effect	Yes (primary indication)
Downtime	Minimal (24–48 hours)	Minimal (24–72 hours)
Anaesthesia	Topical or local	Topical or local
Treatable by dissolution	No	Yes (hyaluronidase enzyme)

Key Clinical Differences Explained

1. Biological Mechanism

The most fundamental difference in P Shot vs Hyaluronic Acid Penile Fillers London lies in the mechanism of action. The P Shot triggers the body’s own regenerative response. PRP growth factors activate stem cells, promote angiogenesis (new blood vessel formation), and stimulate collagen synthesis. As a result, this physiological process unfolds gradually over weeks to months rather than producing immediate visible change.

By contrast, HA fillers work through physical volume augmentation. The gel occupies space beneath the penile skin, producing an immediate increase in circumference. Unlike PRP, HA fillers carry no regenerative component.

2. Treatment Goals

These two procedures target distinctly different patient concerns. The P shot suits men experiencing erectile dysfunction, reduced penile sensitivity, or those who seek tissue-level improvement as part of a broader sexual health plan. However, it does not reliably deliver standalone cosmetic enlargement results.

In contrast, HA penile filler — also referred to as a penis shot for girth — suits men whose primary concern is penile circumference and cosmetic appearance. Because it does not address erectile function, men with ED should complete appropriate clinical assessment and treatment before pursuing a cosmetic penile procedure.

3. Longevity and Maintenance

P shot results vs fillers differ significantly in duration and maintenance requirements. PRP-induced tissue regeneration, when effective, may produce improvements that persist for 12–18 months or longer, since the structural changes occur at the cellular level. Nevertheless, the regenerative response varies between individuals and depends on age, baseline health, and PRP preparation quality.

In comparison, HA penile fillers require repeat treatment every 12–24 months as the hyaluronic acid gradually metabolises. Moreover, clinicians can dissolve HA with hyaluronidase — a significant safety advantage in cases of asymmetry, migration, or adverse outcomes.

4. Safety Profile

Both procedures carry risks, and clinicians must clearly inform patients before proceeding.

The autologous nature of PRP in the P-shot reduces immunological risk, though infection, bruising, and haematoma remain possible. In practice, the primary concern with PRP relates to variable clinical efficacy rather than severe adverse events.

For penis filler UK procedures, risks include bruising, swelling, nodule formation, filler migration, and — in rare cases — vascular occlusion when injection technique is suboptimal. Using a blunt cannula rather than a sharp needle significantly reduces vascular risk. Additionally, the British Journal of Dermatology and multiple aesthetic medicine guidelines recommend that clinicians keep hyaluronidase on-site during all HA filler procedures.

Patients researching penis enlargement surgery near me should note that both the P Shot and HA fillers carry lower risks than surgical alternatives such as ligament division or fat transfer. Nevertheless, ‘lower risk’ does not mean ‘no risk,’ and thorough clinical assessment remains essential.

Who Is Each Procedure Suitable For?

Suitable Candidates for the P Shot

The Priapus Shot is most clinically appropriate for:

•        Men with mild to moderate erectile dysfunction who have not responded adequately to PDE5 inhibitors

•        Men with Peyronie’s disease (penile fibrosis causing curvature and pain)

•        Men who experience reduced sensation following surgery, diabetes, or age-related changes

•        Men seeking penile rehabilitation following radical prostatectomy

What to Expect: P Shot Before and After

The P shot before and after experience involves gradual improvement over 6–12 weeks. Furthermore, some patients report continued progress up to six months post-treatment. Unlike HA fillers, the P Shot produces no immediate visible change — progress builds as PRP growth factors trigger tissue repair at a cellular level.

Suitable Candidates for HA Penile Fillers

HA penile fillers are most clinically appropriate for:

•        Men in good sexual health who seek increased penile girth

•        Men with penile dysmorphic concerns who wish to avoid surgery

•        Men seeking a reversible, non-permanent enhancement

Length vs Girth: A Common Misconception

Penile injection growth through HA fillers increases circumference — not length. This distinction is clinically important and frequently misunderstood. Patients who hold unrealistic expectations about length gain or total penile transformation require thorough counselling before clinicians consider proceeding with treatment.

Cost Considerations

Male enlargement injection costs in UK vary considerably depending on the clinic, practitioner credentials, product volume, and procedural complexity.

P Shot Pricing

For P Shot treatment, London pricing typically ranges from £1500 to £2,500 per session. The Priapus shot price reflects centrifuge equipment, consumables, and clinical time — not the PRP material itself, which the clinician derives directly from the patient’s own blood.

HA Penile Filler Pricing

For HA penile fillers, UK costs generally range from £1,500 to £4,000 depending on the volume of filler required. Additionally, some providers offer staged treatment across multiple sessions, which affects the total cost.

In both cases, male enlargement injection costs should never drive the decision. Patients should instead prioritise practitioner qualifications, clinical governance standards, and the availability of structured aftercare.

What UK Patients Should Know Before Choosing

Both procedures are available at private medical clinics across the UK. The non-surgical penile enhancement London market has expanded significantly in recent years, and patient safety depends heavily on practitioner qualifications and experience.

Verify Practitioner Credentials

Patients should seek treatment from practitioners who hold medical degrees and have completed specific training in genital aesthetics or andrology. Moreover, clinics should offer a thorough consultation, full medical history assessment, and a documented informed consent process before any procedure takes place.

Dr Syed Nadeem Abbas at P shot clinic, a Harley Street-based clinic, offers both PRP penile treatment and HA penile filler procedures under full clinical assessment.

NHS Provision and ED Pathways

The NHS does not routinely fund either the P Shot or penile filler procedures for cosmetic indications. Men who experience erectile dysfunction should first consult their GP, as NHS pathways exist for the assessment and management of ED through urology and sexual health services. Therefore, men should exhaust NHS options before pursuing private non-surgical procedures.

Frequently Asked Questions

Q1: Can I have both the P Shot and hyaluronic acid penile fillers at the same time?

Combining both procedures in the same session is not standard practice. Some clinicians offer them as part of a staged treatment plan, with PRP first to optimise tissue health before filler augmentation. Nevertheless, this approach lacks a robust evidence base, and patients should discuss it fully during consultation.

Q2: How long does a P Shot or penis filler procedure take?

Both procedures typically take 45–90 minutes inclusive of preparation time. The injection itself takes 15–30 minutes.

Q3: Is the P Shot painful?

Clinicians apply topical anaesthetic cream before the procedure, and they may also use a local anaesthetic. Most patients report mild discomfort rather than significant pain during the injection.

Q4: Can hyaluronic acid penile fillers be dissolved if I am unhappy with the results?

Yes. A clinician can inject hyaluronidase enzyme to dissolve HA filler in cases of asymmetry, nodule formation, or patient dissatisfaction. However, dissolution is not always complete, and the process may require multiple treatment sessions.

Q5: Are penile enlargement injections safe?

Both P Shot and HA penile filler injections carry an acceptable safety profile when qualified medical practitioners perform them using sterile technique. Risk increases significantly when unqualified individuals perform procedures in non-clinical settings. Accordingly, patients must verify practitioner credentials before proceeding.

Q6: How soon can I resume sexual activity after these procedures?

Most clinicians advise patients to abstain from sexual activity for 4–7 days following either procedure. This allows initial healing and reduces the risk of filler migration or bruising.

Q7: Do penile fillers affect erection quality?

Clinicians place HA fillers in the subcutaneous tissue of the penile shaft, away from the internal erectile mechanism. Consequently, correctly placed fillers should not impair erection quality. However, overcorrection or filler placed in the wrong anatomical plane can, in rare cases, cause discomfort during erection.

Q8: What is the difference between P Shot results vs fillers in terms of appearance?

HA fillers produce an immediate, visible increase in penile girth. By contrast, the P Shot does not produce immediate visible changes. Any cosmetic improvement from PRP — such as increased firmness during erection — develops gradually and remains modest compared to the physical augmentation that HA fillers achieve.

Key takesaway

The comparison of P Shot vs Hyaluronic Acid Penile Fillers London reveals two procedures that differ fundamentally in mechanism, indication, and outcome. The P Shot is a biological, regenerative treatment with its strongest evidence in erectile dysfunction and tissue repair. In contrast, hyaluronic acid penile fillers are a cosmetic, volume-based procedure suited to men who seek increased penile girth without surgery.

Neither procedure warrants selection without a thorough medical consultation, a clear understanding of realistic outcomes, and an honest assessment of individual health status and expectations. Furthermore, both remain outside NHS provision for cosmetic purposes, and the growing evidence base has not yet reached the standard that formal NICE endorsement requires.

Patients should therefore consult a qualified medical practitioner, review peer-reviewed literature, and critically evaluate clinic credentials before proceeding with either treatment. 

As the market for non-surgical penile enhancement in London continues to expand, the most important question any prospective patient can ask is not ‘which procedure works better?’ — but rather: Am I being assessed by someone with the clinical expertise to determine which procedure, if any, is appropriate for me?

Read more: P Shot London: How to Choose a Safe Clinic and What to Expect at Your Consultation

P Shot UK: What Impacts Price, What Should Be Included in a Quote, and Questions to Ask

P shot London

Erectile dysfunction (ED) affects an estimated 4.3 million men in the United Kingdom. Prevalence rises sharply with age — from around 5% in men aged 20–39 to approximately 70% in those over 70, according to published epidemiological data. Despite this burden, many men receive only first-line pharmacological options such as PDE5 inhibitors.

Two treatments now attract growing clinical interest: the Priapus Shot — known as the P Shot — and testosterone replacement therapy (TRT). Both address aspects of male sexual dysfunction. However, they act through entirely different mechanisms and suit different patient profiles. Clinicians and patients must understand this distinction before choosing a treatment path.

This article provides a structured, evidence-based comparison of the P shot UK landscape and TRT. It examines mechanisms, indications, clinical evidence, limitations, and patient selection.

Understanding the Basics: Two Distinct Approaches

What Is the Priapus Shot (P Shot)?

The Priapus Shot — also written as the p-shot or pshot — is a regenerative medicine procedure using platelet-rich plasma (PRP) drawn from the patient’s own blood. A clinician takes a blood sample, centrifuges it to concentrate platelets and growth factors, and then injects the resulting PRP directly into the corpus cavernosum and surrounding penile tissue.

Practitioners apply the principle that concentrated growth factors – including PDGF, VEGF, and TGF-β — stimulate tissue repair, angiogenesis, and nerve regeneration within erectile tissue. Advocates argue that the P shot treatment addresses structural and vascular causes of ED at a cellular level.

The procedure takes 30–60 minutes under topical anaesthesia. No general anaesthetic or surgical incision is required. Results develop gradually over weeks as tissue remodelling takes place.

What Is Testosterone Replacement Therapy (TRT)?

Testosterone replacement therapy restores circulating testosterone to physiological levels in men with confirmed testosterone deficiency, also termed hypogonadism or testosterone deficiency syndrome (TDS). The NHS provides TRT but applies strict diagnostic criteria to prescribing.

Multiple NHS Integrated Care Board formularies specify that clinicians initiate TRT when total testosterone falls below 8 nmol/L on two early-morning fasting samples taken at least one week apart. The British Society for Sexual Medicine (BSSM) recommends treatment for symptomatic men with total testosterone below 12 nmol/L or free testosterone below 0.225 nmol/L, as set out in their 2023 guidelines.

TRT delivers testosterone via transdermal gels, intramuscular injections (such as Sustanon 250 or Nebido), or patches. Oral testosterone is not recommended due to poor bioavailability and hepatic concerns.

Mechanism of Action: How Each Treatment Works

How the P Shot Works in Erectile Tissue

The intracavernosal injection of PRP targets erectile tissue directly. Platelets contain alpha granules that release growth factors upon activation. Within penile tissue, the proposed mechanisms include:

–     Stimulation of endothelial cell proliferation and new vessel formation, improving penile blood flow

–     Promotion of smooth muscle regeneration within the corpus cavernosum

–     Neuroregeneration via nerve growth factor (NGF) activity

–     Reduction of fibrotic changes linked to age-related or post-surgical ED

A 2023 systematic review in Sexual Medicine Reviews examined 23 studies (7 preclinical and 16 clinical). The review found that preclinical data support the regenerative role of PRP in erectile tissue, consistent with evidence from other tissue types. Randomised clinical studies and the first placebo-controlled trials showed promising efficacy with no major adverse events. The authors note, however, that variability in PRP preparation protocols limits direct comparison between studies.

How Testosterone Replacement Therapy Works

TRT restores hormonal balance through the endocrine system. Testosterone binds to androgen receptors in multiple tissues — including the brain, penis, testes, and skeletal muscle. Within sexual function specifically, testosterone:

–     Modulates sexual desire through hypothalamic and limbic pathways

–     Supports nitric oxide synthase activity, facilitating penile vasodilation

–     Maintains smooth muscle integrity within the corpus cavernosum

–     Regulates PDE5 receptor expression, affecting responsiveness to PDE5i medications

The Society for Endocrinology’s 2022 multi-disciplinary guidelines confirm that TRT improves sexual desire, erection quality, and sexual satisfaction in men with confirmed biochemical hypogonadism. These benefits link specifically to testosterone deficiency — they do not extend to men with low-normal or normal-range testosterone.

 Key distinction: The P shot targets local tissue regeneration within the penis. TRT corrects a systemic hormonal deficit. These are fundamentally different interventions with different targets.

Clinical Indications: Who Is Each Treatment For?

Appropriate Candidates for the P Shot

Clinicians most commonly consider the Priapus shot for men with erectile dysfunction of vasculogenic or neurogenic origin where testosterone levels are normal and hormonal deficiency has been excluded. Specific scenarios include:

–     Vasculogenic ED unresponsive to first-line PDE5i medications

–     Post-prostatectomy ED, where neurovascular bundle damage has occurred

–     ED linked to Peyronie’s disease, where fibrotic plaques impair function

–     Men seeking a non-pharmacological, non-surgical regenerative option

–     Men with mild-to-moderate ED who wish to reduce or avoid long-term PDE5i use

A 2024 systematic review in BMC Urology examined 17 studies, including four randomised controlled trials and 1,099 patients. The review found small-to-moderate benefits in erectile function. Mild and transient side effects appeared across all included studies. No major adverse events were reported.

The P-shot does not hold MHRA approval as a regulated medicine in the UK. It falls within the category of a medical procedure using autologous biological material. Clinical governance responsibility therefore rests with the practitioner. Patients must confirm that any clinician performing penile injection growth procedures holds appropriate qualifications and indemnity.

Appropriate Candidates for TRT

TRT is indicated exclusively for men with symptomatic testosterone deficiency confirmed by biochemical testing. The NHS Norfolk and Norwich University Hospitals Trust guideline on testosterone replacement states clearly that widespread use of testosterone supplementation for ED or non-specific symptoms without confirmed abnormal biochemistry is inappropriate, ineffective, and carries significant risks.

Clinically appropriate TRT candidates present with:

–     Confirmed low morning testosterone on two samples taken between 08:00 and 11:00, at least one week apart

–     Characteristic symptoms of testosterone deficiency: reduced libido, loss of spontaneous erections, fatigue, low mood, or reduced muscle mass

–     Underlying conditions linked to hypogonadism — such as Klinefelter syndrome, pituitary disorders, type 2 diabetes, or long-term opiate use

–     No absolute contraindications including active prostate or testicular cancer, untreated sleep apnoea, or elevated haematocrit

The BSSM 2023 guidelines recommend that clinicians screen for hypogonadism in all men presenting with sexual dysfunction before initiating any ED treatment. Undiagnosed testosterone deficiency is a common and treatable finding.

Reviewing the Evidence Base

Evidence for the P Shot in Erectile Dysfunction

The evidence base for the P-shot — and intracavernosal PRP more broadly — is growing but remains at an early stage of maturity. A 2025 narrative review in UroPrecision searched PubMed, ScienceDirect, and Scopus through December 2024. It identified ongoing trials and highlighted both mechanistic plausibility and methodological limitations in the current literature.

Key findings from published controlled trials include:

–     Poulios et al. (2021) ran a double-blind, randomised, placebo-controlled trial. PRP significantly improved erectile function scores compared with placebo in men with mild-to-moderate vasculogenic ED.

–     Shaher et al. (2023) published a randomised controlled study in Urology. The study found PRP safe and effective in a sample of men with organic ED.

–     Masterson et al. (2023) conducted a prospective, randomised, double-blind, placebo-controlled trial in the Journal of Urology. Their cohort showed no significant benefit from PRP over placebo — a result the researchers presented at the American Urological Association Annual Meeting in 2023.

The divergence in findings reflects a central challenge: PRP preparation is not standardised. Platelet concentration, activation method, injection volume, and injection technique differ between studies and practitioners. As published data in Sexual Medicine Reviews (Oxford Academic, 2023) conclude, evidence is promising and safety is acceptable, but the field lacks the large-scale randomised data required for NICE clinical guidance. Informed consent must make these limitations transparent.

Evidence for Testosterone Replacement Therapy

TRT carries a substantially longer and more robust evidence base. Multiple large-scale randomised controlled trials and systematic reviews establish its efficacy in men with confirmed testosterone deficiency.

The TRAVERSE trial enrolled over 5,000 hypogonadal men and generated important cardiovascular safety data. The BSSM 2023 guidelines reviewed 1,714 articles, including 52 clinical trials and 32 placebo-controlled RCTs, and derived 25 clinical statements supported by Levels 1 to 4 evidence.

For sexual outcomes specifically, TRT in hypogonadal men demonstrates:

–     Improved libido and sexual desire, often apparent within 3–6 weeks of reaching therapeutic testosterone levels

–     Measurable improvement in erection quality when ED arises primarily from androgen deficiency

–     Improved response to PDE5 inhibitors in initially non-responsive men, likely through upregulation of PDE5 receptor expression

–     Secondary benefits including improved energy, mood, cognitive function, bone mineral density, and lean muscle mass

TRT carries a distinct risk profile. Known risks include polycythaemia, testicular atrophy, spermatogenesis suppression leading to infertility, potential acceleration of pre-existing prostate pathology, and transdermal transfer to partners or children in gel users. BSSM and NHS guidelines both mandate regular monitoring of haematocrit, PSA, and clinical symptoms throughout treatment.

P Shot Before and After: What to Expect Realistically

Setting realistic expectations is both a clinical and ethical obligation. P shot before and after outcomes frequently feature in patient enquiries. The following facts govern what the procedure can and cannot achieve.

Timeline of Effects

Improvement in erectile function — if it occurs — is not immediate following the Priapus shot. Tissue remodelling and angiogenesis require time. Practitioners generally advise that:

–     Initial changes may not appear for four to twelve weeks

–     Maximum benefit typically occurs at three to six months post-procedure

–     Some men require more than one treatment session

–     Effects are not permanent; the evidence base does not define a fixed duration of benefit, and repeat treatments may be necessary

Reported Outcomes in the Literature

Studies reporting positive outcomes most consistently note improved erection firmness, enhanced sensitivity, and increased erectile frequency. Some studies also report modest gains in penile dimensions following penile injection growth procedures. However, evidence for size outcomes is less robust. Clinicians must not present size changes as a primary expected outcome. Individual variation is substantial. No ethical or clinically justifiable treatment guarantee exists for any of these outcomes.

Men with severe vascular disease, advanced Peyronie’s disease, or post-surgical anatomical disruption may see limited or no benefit. Thorough pre-procedural assessment and appropriate patient selection are therefore critical.

TRT: Expected Outcomes and Time Course

For men with confirmed hypogonadism, TRT produces measurable improvements across multiple symptom domains. The time course varies by outcome:

–     Libido improvement: often within 3–6 weeks of achieving therapeutic testosterone levels

–     Improved energy and mood: typically 3–6 weeks

–     Erection quality: improvement in androgen-deficiency-related ED may take 3–6 months

–     Muscle mass and body composition: early changes at 3–6 months; full benefit over 12+ months

–     Bone mineral density: improvement detectable at 12–24 months with DEXA scanning

TRT does not uniformly resolve ED in all hypogonadal men. Where ED arises predominantly from vascular disease, diabetic neuropathy, or pelvic surgery, hormonal restoration alone may prove insufficient. In such cases, clinicians may combine TRT with PDE5i therapy or regenerative interventions.

Safety Profiles and Procedural Considerations

P Shot Safety

Published clinical data consistently report a low adverse event profile for intracavernosal PRP injection. The most frequently noted side effects are temporary bruising, mild discomfort at the injection site, and short-term penile swelling. Peer-reviewed literature reports no major adverse events — including priapism, infection, or fibrotic change — across all included studies to date.

The procedure uses autologous material. The patient’s own blood eliminates the risk of systemic allergic reactions. The absence of foreign biological material or exogenous pharmacological agents is a commonly cited clinical advantage over long-term pharmacotherapy.

Practitioners performing the P injection must hold appropriate medical qualifications and operate within a regulated clinical environment. Patients should confirm that the clinic uses MHRA-compliant blood separation equipment and follows standardised aseptic protocols.

TRT Safety and Monitoring Requirements

TRT requires ongoing biochemical and clinical monitoring throughout treatment. NHS and BSSM guidelines specify the following minimum requirements:

–     Full blood count (FBC) to monitor haematocrit — clinicians must review treatment if haematocrit exceeds 52%

–     Serum testosterone at 3 months after initiation, then annually once stable

–     PSA measurement before initiation and annually, with urological assessment if clinically indicated

–     Liver function tests and bone profile as appropriate to the underlying condition

–     Assessment of testicular volume and fertility intentions before commencing therapy, as testosterone suppresses spermatogenesis

TRT is absolutely contraindicated in men with active testicular or prostate cancer, breast cancer, haematocrit above 52%, poorly controlled heart failure, untreated obstructive sleep apnoea, or men actively trying to conceive. These exclusion criteria appear in NHS guidance and BSSM clinical statements.

Access, Cost, and the UK Private Sector

Accessing TRT in the UK

The NHS prescribes TRT but applies strict diagnostic criteria. NHS guidance specifies that a Consultant Endocrinologist or Urologist in secondary care initiates treatment. Once the patient stabilises, monitoring may transfer to primary care.

The process involves an initial GP consultation, two early-morning fasting blood tests at least one week apart, and — where testosterone falls below the prescribing threshold — a referral to an endocrinologist. Many men seek private assessment because of NHS waiting times. In the UK, only a prescription from a registered medical professional lawfully authorises TRT. Self-administration of testosterone from unregulated sources carries significant health and legal risk.

Accessing the P Shot in the UK

The P shot treatment is not available on the NHS. Private medical clinics offer it exclusively. Priapus shot price varies by provider, location, and protocol. In the UK, costs generally range from several hundred to over a thousand pounds per session. Some protocols recommend a series of treatments.

The Priapus shot London market has expanded substantially over the past five years. Patients seeking P shot London service must confirm that a fully qualified doctor leads the clinic, that a medical-grade centrifuge prepares the PRP, and that informed consent documentation clearly addresses both expected and uncertain outcomes.

At pshots.co.uk, Dr Syed Nadeem Abbas (MBBS, MRCS, MRCGP, MSc Aesthetic Plastic Surgery with Distinction — Queen Mary University London, trained at Cambridge, Oxford, and the Royal London Hospital) oversees the procedure.

Male enlargement injections cost UK varies according to the number of sessions and the protocol. Patients should treat any clinic that guarantees specific size outcomes or erectile restoration with considerable caution. No such guarantee is clinically justifiable given current evidence.

Can the P Shot and TRT Be Combined?

These two treatments are not mutually exclusive. A man with confirmed testosterone deficiency and concurrent vasculogenic ED may benefit from both hormonal restoration via TRT and local tissue regeneration via the priapus shot.

The clinical rationale supports this approach. TRT restores androgen-dependent mechanisms of erectile function. PRP addresses structural and vascular tissue at a local level. Many practitioners recommend addressing any hormonal deficiency first, allowing testosterone levels to stabilise, before assessing residual erectile dysfunction that may respond to a regenerative procedure.

No large-scale randomised trials have specifically evaluated the combination of TRT and intracavernosal PRP in the same cohort. This remains an area where clinical practice runs ahead of published evidence. Patients must understand that the combined approach rests on mechanistic rationale and clinical experience, not definitive trial data.

A Practical Decision Framework for Clinicians and Patients

The following framework summarises the key differentiating factors to support structured clinical decision-making.

Consider the P Shot when:

–     Serum testosterone falls within the normal physiological range

–     ED has a predominantly vasculogenic or neurogenic basis

–     First-line PDE5i therapy has proved ineffective or poorly tolerated

–     The patient seeks a non-hormonal, non-surgical regenerative option

–     The patient accepts that the evidence base is promising but not yet definitive

Consider TRT when:

–     Two fasting morning testosterone measurements confirm biochemical deficiency

–     Symptoms are consistent with testosterone deficiency syndrome as defined by BSSM criteria

–     ED accompanies other symptoms of androgen deficiency — reduced libido, fatigue, and mood changes

–     No absolute contraindications are present

–     The patient accepts the need for ongoing monitoring and long-term treatment

Consider further specialist evaluation when:

–     ED is severe, of sudden onset, or accompanied by significant cardiovascular risk factors — NICE clinical knowledge summaries identify ED as a potential marker of underlying cardiovascular disease

–     Both testosterone and erectile function are suboptimal but the clinical picture is ambiguous

–     Fertility preservation is a concern

Limitations of Current Evidence and Future Research Directions

P Shot Evidence Gaps

Methodological heterogeneity is the most substantive limitation in the P shot evidence base. PRP preparation varies in platelet concentration (typically 3–8 times baseline), activation method, injection technique, and treatment frequency. Without standardised protocols, researchers cannot meaningfully compare results between studies.

Regulatory classification also constrains progress. Unlike licensed medicines, PRP procedures do not pass through the systematic clinical trial programme required for MHRA approval. This does not make them inherently unsafe — PRP has a well-established record in orthopaedics and wound care. However, the regulatory safeguards that govern pharmaceutical approval do not apply. Clinicians and patients must interpret this appropriately.

TRT Evidence Gaps

While TRT carries a robust evidence base, certain questions remain open. The long-term cardiovascular safety of TRT in men without pre-existing cardiovascular disease remains an active area of study following the TRAVERSE trial findings. The optimal treatment duration, the impact on fertility recovery after cessation, and the precise testosterone threshold at which benefits clearly outweigh risks remain areas of clinical disagreement between the BSSM, NHS commissioning bodies, and European Association of Urology guidelines.

Conclusion: Two Different Solutions for Different Clinical Problems

The P Shot and testosterone replacement therapy address male sexual dysfunction through fundamentally different mechanisms. They are appropriate for fundamentally different patient profiles. Neither is interchangeable, and neither offers a universal solution to erectile dysfunction.

TRT has a well-established evidence base, clear NHS prescribing criteria, and a defined risk-monitoring framework. It is the correct intervention for men with confirmed testosterone deficiency and its associated symptom burden. Administering it to men with normal testosterone levels is neither effective nor safe.

The P shot occupies a different clinical space. It offers a regenerative, non-hormonal, non-surgical approach for men with vasculogenic or structural ED who maintain normal hormone levels. The evidence base is growing and biologically plausible. Safety data across published studies are acceptable. However, the procedure has not yet reached the evidence threshold required for NICE guidance. Clinicians must communicate this reality clearly.

A rigorous pre-treatment evaluation — including serum testosterone measurement, cardiovascular risk assessment, and a thorough sexual history — is the necessary starting point regardless of which pathway a clinician considers. Patients who receive accurate diagnoses and treatment aligned to the underlying cause of their dysfunction achieve the most meaningful benefit.

The most clinically important question is not which treatment is superior — it is whether the correct investigation has been performed to determine which condition is actually present.

Read more: P Shot UK: What Impacts Price, What Should Be Included in a Quote, and Questions to Ask

P Shot London: How to Choose a Safe Clinic and What to Expect at Your Consultation

P shot London

Erectile dysfunction affects a large number of men across the UK. NHS England data shows that roughly 50% of men aged between 40 and 70 experience some degree of the condition. That number rises with age. Despite this, many men put off seeking help. Embarrassment plays a role, but so does confusion about which treatments are available and how they work.

Two options draw increasing interest in private men’s health clinics — the P Shot and low-intensity shockwave therapy. Both are non-surgical, aim to improve erectile function and work through regenerative processes. Yet they take very different approaches. This article breaks down how each treatment works, what the evidence shows, and what to think about before choosing.

What Is the P Shot?

How the Treatment Works

The P Shot — short for the Priapus Shot — is a regenerative injection treatment for men. It uses platelet-rich plasma (PRP), taken from the patient’s own blood, and places it directly into penile tissue. Dr Charles Runels developed the treatment in the United States. The name comes from Priapus, the Greek god of fertility.

To prepare the injection, a clinician takes a small blood sample from the patient. A centrifuge spins the sample to separate it into layers. This process concentrates the platelets, which carry growth factors that support tissue repair. The clinician then injects the resulting PRP into the corpus cavernosum — the sponge-like tissue that fills with blood during an erection — and into the glans. A topical anaesthetic cream reduces discomfort before the injections begin.

The Biology Behind the P Shot

The P-shot works on the same biological principles that support PRP use in orthopaedics, dermatology, and wound care. Growth factors within the PRP — including PDGF, VEGF, and TGF-β — stimulate new blood vessel growth, support smooth muscle function, and aid nerve tissue. These effects directly address the vascular and tissue changes that contribute to erectile dysfunction.

What the Evidence Shows

Published P-shot before and after data from case series report improvements in erectile firmness, sensitivity, and in some cases penile dimensions. Individual results vary. A 2021 review in Sexual Medicine Reviews found that PRP for erectile dysfunction produced encouraging early results, particularly in men with mild-to-moderate vascular dysfunction. The authors called for larger randomised controlled trials to confirm these findings.

Cost and Availability in the UK

Men looking for P shot treatment in the UK will find it most commonly in specialist private clinics. P shot London providers concentrate largely around Harley Street and other private medical settings. The priapus shot price in the UK typically falls between £1500 and £2500 per session. Pricing depends on the clinic, the clinician’s qualifications, and whether the clinic includes other treatments in the package. When researching male enlargement injections cost UK, it pays to check the clinical credentials behind the service rather than comparing price alone.

What Is Shockwave Therapy for Erectile Dysfunction?

How the Treatment Works

Low-intensity extracorporeal shockwave therapy — known as Li-ESWT — uses acoustic waves to stimulate tissue repair in the penis. A clinician applies a handheld probe to the outside of the penis. The device sends low-energy sound waves into the erectile tissue. No injections take place. No anaesthetic is needed. Most men describe a mild buzzing or pressure sensation during the session.

A standard course runs to four to six sessions. Each session lasts between 15 and 20 minutes. Men can return to normal activity straight afterwards.

How Shockwave Therapy Differs From Other Uses

High-energy shockwave devices break up kidney stones in urology. Li-ESWT works at much lower energy levels. The goal is not destruction but stimulation. The acoustic waves create minor disruption at a cellular level, which triggers the body’s natural repair response. This drives new blood vessel growth and increases nitric oxide availability. Nitric oxide relaxes smooth muscle and improves blood flow — both essential for healthy erections.

What the Research Shows

A 2019 meta-analysis in The Journal of Sexual Medicine pooled data from 14 randomised controlled trials. It found meaningful improvements in erectile function scores for men who received Li-ESWT compared to those who received sham treatment. The benefit was strongest in men with vasculogenic erectile dysfunction – dysfunction caused by poor blood supply.

NICE reviewed shockwave therapy for erectile dysfunction in its interventional procedures guidance. It noted short-term improvements across multiple studies. NICE also states that clinicians should only offer the procedure within proper governance frameworks and with specific training. The guidance acknowledges that long-term data remains limited.

How Do the Two Treatments Compare?

Mechanism of Action

The P-shot and shockwave therapy both target the vascular and tissue damage that drives erectile dysfunction. They reach that goal through different routes.

The p-shot delivers growth factors directly into penile tissue through injection. It uses the patient’s own platelets to drive cellular repair from within the tissue.

Shockwave therapy works from the outside. The device converts electrical energy into acoustic wave energy. Those waves penetrate the tissue and start a repair cascade without breaking the skin.

Some clinics combine both treatments. The two mechanisms can work alongside each other effectively.

Invasiveness and What to Expect

The P-shot involves injections, which makes it more hands-on than shockwave therapy. Clinicians apply anaesthetic cream first. The procedure takes around 30 minutes. Most men tolerate it well. There is no recovery period.

Shockwave therapy involves no needles. The probe sits against the skin throughout. Sessions are short. Men leave the clinic and carry on with their day. For men who want to avoid any form of penile injection growth procedure, shockwave therapy offers a lower-threshold starting point.

Comparing the Evidence

Both treatments have supporting evidence. Neither yet has the volume of trial data that a Cochrane-level review would require.

The P-shot evidence base includes case series and cohort studies. A 2020 pilot RCT in The Journal of Sexual Medicine showed improvements in erectile function scores for men who received PRP compared to those who received a placebo. The trial was small, but the results were positive.

The shockwave therapy evidence base is more developed. Multiple RCTs and meta-analyses exist, particularly for vasculogenic dysfunction. Shockwave therapy has also shown it can restore a man’s response to PDE5 inhibitors — medications like sildenafil — in cases where the drugs had stopped working.

Who Each Treatment Suits

The P-shot tends to suit men with mild-to-moderate erectile dysfunction that has a vascular cause, men whose oral medications have not produced adequate results, and men who want improvements in sensitivity and sexual satisfaction alongside better erections. It also suits men open to a pshot protocol that involves more than one session.

Shockwave therapy tends to suit men who prefer a non-injectable option, men with vasculogenic dysfunction where the evidence is strongest, and men who want to regain their response to oral medication before considering other treatments.

How Long Result Last

P-shot before and after data from clinical studies suggest that results can last between 12 and 18 months. Individual variation is wide.

Shockwave therapy results in the published literature typically hold for around 12 months. Some studies report sustained improvements at the two-year mark.

Neither treatment produces a permanent result. Clinicians often discuss maintenance sessions based on how the individual responds.

Safety Considerations

Both treatments carry a low risk of side effects when a qualified clinician performs them.

The p-shot uses the patient’s own blood, so allergic reaction or rejection is not a concern. Side effects are minor and short-lived. These include light bruising, temporary swelling, or mild sensitivity at the injection site.

Shockwave therapy side effects are also mild. Some men notice brief redness or slight discomfort during or after a session. Both treatments avoid the systemic side effects that come with long-term oral medication use.

What to Consider Before Choosing

Several factors shape the right choice: the cause of erectile dysfunction, how long the problem has existed, prior treatment history, and personal comfort with injections versus a non-invasive device.

Get a Clinical Assessment First

A proper medical assessment matters before starting either treatment. Erectile dysfunction often signals an underlying health issue. Cardiovascular disease, metabolic syndrome, and neurological conditions all affect erectile function. The NHS recommends that men with erectile dysfunction check blood pressure, blood glucose, and lipid levels. A good private clinic will carry out this assessment before suggesting any treatment.

Consider Combined Protocols

Some men benefit most from a combination approach. A clinician may recommend shockwave therapy first to improve blood flow, followed by the P-shot to support tissue repair at a cellular level. Others may need only one treatment. The right protocol depends on clinical findings, not a one-size-fits-all formula.

At pshots.co.uk, Dr Syed Nadeem Abbas — MBBS, MRCS, MRCGP, and MSc in Aesthetic Plastic Surgery with Distinction from Queen Mary University London — leads a Harley Street men’s health clinic that offers both PRP-based P shot treatment and combination protocols under full clinical governance.

The Bottom Line

The P Shot and shockwave therapy each offer a distinct approach to erectile dysfunction. The Priapus shot places growth factors directly into penile tissue using the patient’s own blood. Shockwave therapy stimulates the same type of tissue repair using acoustic waves from outside the body.

Both treatments have a growing evidence base and a strong safety record. Neither replaces a clinical assessment, and neither addresses underlying health conditions on its own. The right starting point is always a consultation with a qualified clinician. From there, the choice between the P-shot, shockwave therapy, or a combination of both becomes a clinical decision — not a guessing game.

Read more: P Shot London – What You Need to Know Before Treatment

P Shot Treatment: Procedure Steps, Recovery, Aftercare, and Results Timeline

P shot London